US10722359B2 - Heart valve docking devices and systems - Google Patents

Heart valve docking devices and systems Download PDF

Info

Publication number
US10722359B2
US10722359B2 US15/902,956 US201815902956A US10722359B2 US 10722359 B2 US10722359 B2 US 10722359B2 US 201815902956 A US201815902956 A US 201815902956A US 10722359 B2 US10722359 B2 US 10722359B2
Authority
US
United States
Prior art keywords
docking device
valve
tip
coil
coiled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US15/902,956
Other languages
English (en)
Other versions
US20180177594A1 (en
Inventor
Darshin S. Patel
Boaz Manash
Khen Perlmutter
Eyal Leiba
Yoav Rozen
Dinesh L. Sirimanne
Tri D. Tran
Jocelyn Chau
Noa Axelrod
Zohar Kiblitski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Edwards Lifesciences Corp
Original Assignee
Edwards Lifesciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/682,287 external-priority patent/US10463479B2/en
Application filed by Edwards Lifesciences Corp filed Critical Edwards Lifesciences Corp
Priority to US15/902,956 priority Critical patent/US10722359B2/en
Priority to AU2018409826A priority patent/AU2018409826B2/en
Priority to IL314204A priority patent/IL314204A/en
Priority to SG11202007778XA priority patent/SG11202007778XA/en
Priority to JP2020544517A priority patent/JP7177162B2/ja
Priority to KR1020207026802A priority patent/KR102581821B1/ko
Priority to CA3090478A priority patent/CA3090478A1/en
Priority to EP24177295.3A priority patent/EP4397279A3/en
Priority to PCT/US2018/019545 priority patent/WO2019164516A1/en
Priority to BR112020016300-7A priority patent/BR112020016300B1/pt
Priority to IL276763A priority patent/IL276763B1/en
Priority to CN201880091923.9A priority patent/CN111970993B/zh
Priority to BR122020025121-2A priority patent/BR122020025121B1/pt
Priority to MX2020008522A priority patent/MX2020008522A/es
Priority to EP18907294.5A priority patent/EP3755269A4/en
Priority to NZ766755A priority patent/NZ766755A/en
Priority to CN202410373028.3A priority patent/CN118252670A/zh
Priority to KR1020237032012A priority patent/KR20230143617A/ko
Assigned to EDWARDS LIFESCIENCES CORPORATION reassignment EDWARDS LIFESCIENCES CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: TRAN, TRI D., CHAU, JOCELYN, KIBLITSKI, ZOHAR, ROZEN, Yoav, AXELROD, Noa, LEIBA, Eyal, MANASH, BOAZ, PERLMUTTER, Khen, SIRIMANNE, DINESH L., PATEL, DARSHIN S.
Publication of US20180177594A1 publication Critical patent/US20180177594A1/en
Priority to US16/933,632 priority patent/US11801133B2/en
Publication of US10722359B2 publication Critical patent/US10722359B2/en
Application granted granted Critical
Priority to MX2024005354A priority patent/MX2024005354A/es
Priority to AU2022211922A priority patent/AU2022211922B2/en
Priority to JP2022179734A priority patent/JP2023010781A/ja
Priority to US18/330,252 priority patent/US20230310152A1/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2463—Implants forming part of the valve leaflets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2409—Support rings therefor, e.g. for connecting valves to tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
    • A61F2/2418—Scaffolds therefor, e.g. support stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427—Devices for manipulating or deploying heart valves during implantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427—Devices for manipulating or deploying heart valves during implantation
    • A61F2/243—Deployment by mechanical expansion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2427—Devices for manipulating or deploying heart valves during implantation
    • A61F2/2436—Deployment by retracting a sheath
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
    • A61F2/2466—Delivery devices therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
    • A61B2017/00238—Type of minimally invasive operation
    • A61B2017/00243—Type of minimally invasive operation cardiac
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95—Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2002/9528—Instruments specially adapted for placement or removal of stents or stent-grafts for retrieval of stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0063—Three-dimensional shapes
    • A61F2230/0091—Three-dimensional shapes helically-coiled or spirally-coiled, i.e. having a 2-D spiral cross-section
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/006—Additional features; Implant or prostheses properties not otherwise provided for modular
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/006—Additional features; Implant or prostheses properties not otherwise provided for modular
    • A61F2250/0063—Nested prosthetic parts

Definitions

  • the invention generally relates to medical devices and procedures pertaining to prosthetic heart valves. More specifically, the invention relates to replacement of heart valves that may have malformations and/or dysfunctions.
  • Embodiments of the invention relate to an anchor or docking device that can hold and maintain a positioning of a prosthetic heart valve for replacing the function of a native heart valve, for example, for a mitral or tricuspid valve replacement procedure, as well as deployment procedures associated with the implantation of such an anchor or docking device and/or of an assembly including the anchor or docking device and a prosthetic heart valve.
  • the mitral valve 50 controls the flow of blood between the left atrium 52 and the left ventricle 54 of the human heart. After the left atrium 52 receives oxygenated blood from the lungs via the pulmonary veins, the mitral valve 50 permits the flow of the oxygenated blood from the left atrium 52 into the left ventricle 54 . When the left ventricle 54 contracts, the oxygenated blood that was held in the left ventricle 54 is delivered through the aortic valve 56 and the aorta 58 to the rest of the body. Meanwhile, the mitral valve should close during ventricular contraction to prevent any blood from flowing back into the left atrium.
  • chordae tendineae 62 When the left ventricle contracts, the blood pressure in the left ventricle increases substantially, which serves to urge the mitral valve closed. Due to the large pressure differential between the left ventricle and the left atrium during this time, a large amount of pressure is placed on the mitral valve, leading to a possibility of prolapse, or eversion of the leaflets of the mitral valve back into the atrium.
  • a series of chordae tendineae 62 therefore connect the leaflets of the mitral valve to papillary muscles located on the walls of the left ventricle, where both the chordae tendineae and the papillary muscles are tensioned during ventricular contraction to hold the leaflets in the closed position and to prevent them from extending back towards the left atrium. This helps prevent backflow of oxygenated blood back into the left atrium.
  • the chordae tendineae 62 are schematically illustrated in both the heart cross-section of FIG. 1 and the top view of the mitral valve of FIG. 2 .
  • FIG. 2 A general shape of the mitral valve and its leaflets as viewed from the left atrium is shown in FIG. 2 .
  • Commissures 64 are located at the ends of the mitral valve 50 where the anterior leaflet 66 and the posterior leaflet 68 come together.
  • Various complications of the mitral valve can potentially cause fatal heart failure.
  • mitral valve leak or mitral regurgitation characterized by abnormal leaking of blood from the left ventricle through the mitral valve back into the left atrium.
  • valve replacement While open surgical procedure options are more readily available, there has been much less development in terms of commercially available ways to replace a mitral valve through catheter implantation and/or other minimal or less invasive procedures.
  • the field of transcatheter aortic valve replacement has developed much more and has gained widespread success.
  • This discrepancy stems, in part, from replacement of a mitral valve being more difficult than aortic valve replacement in many respects, for example, due to the non-circular physical structure of the mitral valve, its sub-annular anatomy, and more difficult access to the valve. Due to the successes in the development of transcatheter aortic valve technology, it could be beneficial to use the same or similar circular valve prostheses for mitral valve replacements.
  • mitral valve replacement One of the most prominent obstacles for mitral valve replacement is effective anchoring or retention of the valve at the mitral position, due to the valve being subject to a large cyclic load.
  • another issue with mitral valve replacement is the size and shape of the native mitral annulus, as can be seen in FIG. 2 .
  • Aortic valves are more circular or cylindrical in shape than mitral valves.
  • the mitral and tricuspid valves are both larger than the aortic valve, and more elongate in shape, making them more difficult and unconventional sites for implanting a replacement valve with a generally circular or cylindrical valve frame.
  • a circular prosthetic valve that is too small can result in leaking around the implant (i.e., paravalvular leakage) if a good seal is not established around the valve, while a circular prosthetic valve that is too large can stretch out and damage the narrower parts of the native mitral annulus.
  • the need for aortic valve replacement arises due, for example, to aortic valve stenosis, where the aortic valve narrows due to calcification or other hardening of the native leaflets. Therefore, the aortic annulus generally forms a more compact, rigid, and stable anchoring site for a prosthetic valve than the mitral annulus, which is both larger than the aortic annulus and non-circular.
  • One way to apply existing circular or cylindrical transcatheter valve technology to non-circular valve replacement would be to use an anchor (e.g., a mitral anchor) or docking device or docking station that forms or otherwise provides a more circular docking site at the native valve position (e.g., mitral valve position) to hold such prosthetic valves.
  • an anchor e.g., a mitral anchor
  • docking device or docking station that forms or otherwise provides a more circular docking site at the native valve position (e.g., mitral valve position) to hold such prosthetic valves.
  • existing expandable transcatheter valves developed for the aortic position, or similar valves that have been slightly modified to more effectively replicate mitral valve function could be more securely implanted in such docking devices positioned at the native valve annulus (e.g., native mitral annulus).
  • the docking device can first be positioned at the native valve annulus, and thereafter, the valve implant or transcatheter heart valve can be advanced and positioned through the docking device while in a collapsed position, and can then be expanded, for example, via self-expansion (e.g., in the case of valves that are constructed with NiTi or another shape memory material), balloon expansion, or mechanical expansion, so that the frame of the prosthetic valve pushes radially against the docking device and/or tissue between the two to hold the valve in place.
  • self-expansion e.g., in the case of valves that are constructed with NiTi or another shape memory material
  • balloon expansion e.g., in the case of valves that are constructed with NiTi or another shape memory material
  • the docking device can also be delivered minimally or less invasively, for example, via the same or similar transcatheter approaches as used for delivery of a transcatheter heart valve, so that a completely separate procedure is not needed to implant the docking device prior to delivery of the prosthetic valve.
  • Embodiments of the invention provide a stable docking station or docking device for retaining a prosthetic valve (e.g., a prosthetic mitral valve). Other features are provided to improve the deployment, positioning, stability, and/or integration of such docking stations and/or replacement prostheses intended to be held therein. These devices and methods will more securely hold prosthetic valves, and can also prevent or greatly reduce regurgitation or leaking of blood around the prosthetic valves. Such docking devices and methods can be used for various valve replacement procedures, for example, for mitral, tricuspid, pulmonary, or aortic valve replacements, to provide more secure and robust anchoring and holding of valve implants at the native annuluses at those positions.
  • Docking devices for docking a prosthetic valve at a native valve (e.g., mitral valve, tricuspid valve, etc.) of a heart can include various features, components, and characteristics.
  • such docking devices can include a coiled anchor that has at least one central turn (e.g., a full rotation or partial-rotation central turn) defining a central turn diameter.
  • the at least one central turn can be one or more functional turns/coils.
  • the coiled anchor can also include a lower turn extending from the at least one central turn defining a diameter that is greater than the central turn diameter.
  • the lower turn can be a leading turn/coil.
  • the coiled anchor can also include an upper turn connected to the central turn.
  • the upper turn can be one or more stabilizing turns/coils.
  • the upper turn can be shaped to have a first diameter along a first axis and a second diameter along a second axis.
  • the first axis diameter of the upper turn can be greater than the central turn diameter
  • the second axis diameter can be greater than the central turn diameter and less than the lower turn diameter.
  • the various coiled anchors described herein can be configured to be implanted at the native valve (e.g., native mitral valve, tricuspid valve, etc.) with at least a portion of the at least one central turn of the coiled anchor positioned in a chamber (e.g., a left ventricle) of the heart and around valve leaflets of the native valve.
  • any of the coiled anchors described herein can also include an extension having a length extending from an upper end of the at least one central turn to an upper turn/coil or stabilization turn/coil.
  • the extension can have a smaller or reduced thickness compared to other parts of the coiled anchor, e.g., the at least one central turn, upper turn, lower turn, etc.
  • the extension can extend vertically at an angle between 60-120 degrees, 70-110 degrees, 80-100 degrees, 90 degrees relative to the at least one central turn.
  • the various docking devices for docking a prosthetic valve at a native valve of a heart can have a coiled anchor (e.g., which can be the same as or similar to other coiled anchors described in this disclosure) that has a proximal tip and a distal tip.
  • the coiled anchor can include at least one central turn (e.g., a full or partial central turn, which can be the same as or similar to other central or functional turns described in this disclosure).
  • the at least one central turn can have a first thickness and define a central turn diameter.
  • Any of the coiled anchors described herein can also include an extension having a length extending from an upper end of the at least one central turn.
  • the coiled anchor can also include an upper turn (e.g., with can be the same as or similar to other upper turns or stabilizing turns/coils described in this disclosure) extending from an upper end of the extension.
  • the extension can have a second thickness that is less than the first thickness.
  • the upper turn can have a third thickness that is greater than the second thickness.
  • the coiled anchor can configured to be implanted at the native valve (e.g., native mitral valve, tricuspid valve, etc.) with at least a portion of the at least one full or partial central turn of the coiled anchor positioned in a chamber (e.g., left ventricle) of the heart and around valve leaflets (e.g., mitral valve leaflets) of the native heart valve.
  • the various docking devices for docking a prosthetic valve at a native valve of a heart can also have a coiled anchor (e.g., which can be the same as or similar to other coiled anchors described in this disclosure) that has a proximal tip and a distal tip and at least one central turn (e.g., a full or partial central turn, which can be the same as or similar to other central turns/coils or functional turns/coils described in this disclosure) that defines a diameter.
  • the coiled anchor can also have an upper turn that is connected to the at least one central turn.
  • a cover layer can surround the coiled anchor along all or at least a part of the at least one central turn. The cover layer can be connected to the coiled anchor.
  • At least one friction enhancing layer can be disposed over the coiled anchor and/or the cover layer.
  • the at least one friction enhancing layer can be disposed over at least a portion of the at least one central turn.
  • the coiled anchor can be configured such that no portion of the upper turn is covered by the friction enhancing layer.
  • the coiled anchor can also be configured to be implantable at a native valve (e.g., a native mitral valve, etc.) with at least a portion of the at least one central turn of the coiled anchor positioned in a chamber (e.g., left ventricle) of the heart and around valve leaflets of the native valve.
  • any of the coiled anchors of any of the docking devices described herein can include one or more cover layers that surround all or at least part of the coiled anchor or a core of the coiled anchor.
  • a cover layer can surround all or at least part of the at least one central turn (or all of the central turn(s)/coil(s) or functional turn(s)/coil(s) of the coiled anchor) and/or other parts of the coiled anchor.
  • the cover layer can be connected to the coiled anchor in various ways.
  • the cover layer can be a high friction cover layer, a low friction cover layer, or both a low friction cover layer and a high friction cover layer used together.
  • the low friction cover layer can be configured to surround a core of the coiled anchor (e.g., the full length of the coiled anchor) and extend past the proximal tip and/or distal tip.
  • the low friction cover layer can form a tapered or rounded tip at its distal end and/or at its proximal end.
  • a high friction cover layer or higher friction cover layer (e.g., higher than the low friction cover layer) can surround a portion of the low friction cover layer and/or a portion of the coiled anchor (e.g., all or a part of the at least one central turn).
  • any of the coiled anchors described herein can include at least one friction enhancing element or multiple friction enhancing elements.
  • the at least one friction enhancing element or friction enhancing elements can be positioned over all or a portion of the coiled anchor or a covering/layer on the coiled anchor.
  • the at least one friction enhancing element can be or include a plurality of bulges on the surface of the coiled anchor or on the surface of the covering.
  • the bulges can be made of PET, polymer, fabric, or another material.
  • the bulges can extend along a length of the coiled anchor or the covering along at least a part of the central turn(s)/coil(s).
  • the at least one friction enhancing element can be or include a plurality of lock and key cutouts in an outer surface of the coiled anchor.
  • the lock cutouts can be grooves formed in the outer surface of the coiled anchor, and the key cutouts can be protrusions extending outward from the coiled anchor, which can be sized and shaped to fit into the lock cutouts.
  • Systems for implanting a docking device at a native valve of a heart can include a docking device (e.g., any docking device described above or elsewhere in this disclosure).
  • the docking device can include an opening or bore, and the system can include a suture threaded through the opening or bore.
  • the system can also include a delivery catheter, and a pusher device disposed in the delivery catheter.
  • the pusher device can include a central lumen that accepts the suture or through which the suture passes.
  • the pusher device and suture can be arranged such that pulling the suture pulls the coiled anchor against the pusher device, and retracting the pusher device into the delivery catheter retracts the coiled anchor into the delivery catheter.
  • the suture can be disposed in the central lumen such that pulling the suture and/or the pusher device proximally relative to the delivery catheter retracts the coiled anchor or delivery device into the delivery catheter.
  • a docking device for docking a prosthetic valve at a native valve of a heart can have a coiled anchor that includes a hollow tube.
  • the hollow tube can have a proximal lock feature and a distal lock feature.
  • the cuts can have a pattern and shape that incorporates one or both of longitudinal and transverse cuts. Where the cuts have a pattern and shape that incorporate both longitudinal and transverse cuts, these can form teeth and grooves in the hollow tube.
  • the docking device can also have a wire, and the distal end of the wire can be secured to the distal lock feature.
  • a length of the wire (e.g., the full length or a portion thereof) can extend through the hollow tube and apply a radially inward tension on the hollow tube.
  • the hollow tube is configured to at least partially encircle leaflets of a native mitral valve and provide a docking surface for an expandable prosthetic valve.
  • Methods used to implant a docking device for a prosthetic valve at a native heart valve can include a variety of steps (e.g., any of the steps described throughout this disclosure).
  • the docking device implanted with these methods can be any of the docking devices described herein.
  • a docking device implantable with these steps can have a coiled anchor having at least one full or partial turn defining a central diameter, an extension having a length extending from an upper end of the at least one central turn, and an upper turn extending from an upper end of the extension.
  • a delivery catheter can be positioned into a first chamber (e.g., a left atrium) of a heart.
  • the delivery catheter can be advanced and positioned through a guide sheath previously implanted.
  • the delivery catheter can contain the docking device in a first configuration.
  • a distal end of a docking device can be advanced from the delivery catheter so that the docking device adopts a second configuration as it is advanced and/or when it is implanted.
  • the docking device is advanced through a valve annulus (e.g., a native mitral valve annulus) and into a second chamber of the heart (e.g., the left ventricle) such that a distal tip loosely encircles any chordae and native leaflets of the native valve (e.g., of a mitral valve).
  • the extension of the docking device can be advanced such that its upper end is positioned in the first chamber (e.g., the left atrium).
  • the upper portion of the docking device can be advanced into the first chamber (e.g., the left atrium) and released, such that the upper portion is in contact with the first chamber wall (e.g., the left atrium wall).
  • a replacement prosthetic valve can be implanted in the docking device.
  • a replacement valve can be inserted in an inner space defined by the docking device in the second configuration.
  • the replacement valve can be radially expanded until there is a retention force between the replacement valve and the docking device to hold the replacement valve in a stable position. Native leaflets or other tissue can be clamped between the delivery device and the prosthetic valve.
  • Valve replacement can be realized through the use of a coiled anchor or docking device at the native valve site for docking an expandable transcatheter heart valve therein.
  • the coiled anchors or docking devices provide a more stable base or site against which the prosthetic valves can be expanded.
  • Embodiments of the invention thus provide a more robust way to implant a replacement heart valve, even at sites such as a native mitral annulus, where the annulus itself may be non-circular or otherwise variably shaped.
  • One or more of the systems herein can be for implanting a docking device at a native valve and/or retrieving a docking device.
  • the systems can comprise various features and components described herein including a delivery catheter, and a coiled docking device (e.g., an elongated coiled docking device) having an end portion.
  • the systems can also include a pusher device having a central lumen, wherein the pusher device can be disposed in the delivery catheter.
  • a retrieval line e.g., a retrieval suture
  • the systems are configured to facilitate pulling the docking device against the pusher device and/or into a delivery catheter without causing the end portion or docking device to get caught on or T at the end of the pusher device and/or delivery catheter.
  • the systems e.g., the end portion and retrieval line
  • the systems are configured such that pulling the retrieval line pulls the end portion of the coiled anchor against the pusher device and/or delivery catheter in a way that helps guide the end portion and docking device into the delivery catheter.
  • the proximal-most portion or tip of the end portion can be curved to help align the end portion with the pusher tube and/or delivery catheter for retrieval.
  • the end portion and retrieval line can also be configured and coupled such that a tension force from the pulling is biased to be substantially aligned with a central axis of the end portion of the coiled docking device or such that pulling the retrieval line biases the tension force to be aligned with the central axis of the end portion of the coiled docking device.
  • the tension force can bias the central axis of the end portion to align or be aligned with an axis of the pusher device and/or delivery catheter as well, e.g., so the end portion lines up for retraction into the delivery catheter.
  • the end portion can be configured to align at least a lengthwise portion of the retrieval line along the central axis.
  • the retrieval line can be arranged to extend through a central passage at a tip of the end portion of the docking device.
  • the central passage can be aligned with or be coaxial with the central axis.
  • the docking device can comprise a spherical tip (e.g., ball shaped, semispherical, hemispherical, etc.).
  • the spherical tip can be configured to receive the retrieval line through a passage that is aligned with central axis of the end portion of the coiled docking device.
  • the proximal tip can comprise an annular groove in a transition portion of the proximal tip.
  • a distal end of the pusher device can be configured to engage a spherical surface at the end portion of the coiled anchor, and a portion of the spherical tip can be pulled somewhat into a lumen of the pusher device.
  • the end portion of the docking device can comprises tip with a loop, wherein the retrieval line can be connected to the loop.
  • the end portion of the docking device can comprises tip with a groove, wherein the retrieval suture can be coupled to the end portion in the groove, e.g., tied into the groove, coupled to a suture loop in the groove, wound at least partially in the groove, etc.
  • the coiled docking device of the system(s) can include at least one central turn having a first thickness and defining a central turn diameter; an extension or transition having a length extending from a proximal end of the at least one central turn, the extension having a second thickness that is less than the first thickness; a proximal or upper turn extending from a proximal or upper end of the extension.
  • the proximal turn can have a third thickness that is greater than the second thickness.
  • the coiled docking device can also comprise a distal or lower turn on an opposite end of the coiled docking device from the proximal or upper turn and the end portion.
  • the distal or lower turn can have the first thickness and can define a diameter that is greater than the central turn diameter.
  • the end portion of the coiled docking device can be at a proximal end of the proximal turn.
  • the coiled docking device is configured to be implanted at the native valve with at least a portion of the coiled docking device positioned in a chamber of the heart and around valve leaflets of the native valve.
  • the coiled docking device can be configured to be implanted at the native mitral valve with at least a portion of the coiled docking device positioned in the left ventricle and around mitral valve leaflets of the native mitral valve.
  • the coiled docking device can be configured to be implanted at the native tricuspid valve with at least a portion of the coiled docking device positioned in the left ventricle and around tricuspid valve leaflets of the native tricuspid valve.
  • the system and/or coiled docking device can include a cover layer comprising a biocompatible material, wherein the cover layer surrounds at least a portion of the coiled anchor.
  • the cover layer can be a low friction cover layer, having a distal end and a proximal end.
  • the cover layer can surround the coiled docking device and extend along a length of the coiled docking device, past a distal tip of the coiled docking device, and past a proximal tip of the coiled docking device, the low friction cover layer tapering to a rounded tip at its distal end.
  • the system and/or coiled docking device can include a friction enhancing element, and the friction enhancing element can comprise a second cover layer surrounding and extending along at least a portion of the cover layer, wherein the second cover layer provides a coefficient of friction of at least 1 (or one of the other friction enhancing elements described elsewhere herein).
  • the second cover layer can be a braided material.
  • the coiled docking device can comprise at least one central turn defining a central turn diameter, a distal or lower turn extending from the at least one central turn defining a distal or lower turn diameter that is greater than the central turn diameter, and an upper or proximal turn connected to the at least one central turn, the upper or proximal turn being shaped to have a first diameter along a first axis and a second diameter along a second axis.
  • the first axis diameter can be greater than the central turn diameter
  • the second axis diameter can be greater than the central turn diameter and less than the lower or distal turn diameter.
  • the coiled docking device can comprises a hollow tube having a proximal end and a distal end and a plurality of cuts through portions of the tube. It can also comprise a wire having a length, a proximal end, and a distal end. The distal end of the wire can be secured to a distal end of the hollow tube and the proximal end of the wire can be secured to a proximal end of the hollow tube. The length of the wire can extend through the hollow tube and applies a radially inward tension on the hollow tube.
  • the cuts can have a pattern and shape that incorporates both longitudinal and transverse cuts forming teeth and grooves in the hollow tube.
  • the coiled docking device can include a skeleton or core, and a distal end of the skeleton or core can have a rectangular cross-section and a distal ring-shaped tip.
  • the coiled docking device can include a skeleton or core, and at least one end of the skeleton or core can have a ball-shaped tip.
  • a docking device for docking a prosthetic valve at a native valve of a heart can include any of the features and components described with respect to the docking devices above and elsewhere herein.
  • it can include or be a coiled docking device having an end portion with a central axis.
  • the end portion of the docking device can be configured such that a retrieval suture connected to the end portion will be biased to cause a line of force applied by tension to the retrieval suture to be aligned with the central axis.
  • Methods of retrieving a coiled docking device from within a heart can comprise pulling a retrieval line to pull an end portion of a coiled docking device against a pusher device and/or into a delivery catheter.
  • the end portion of the coiled docking device can configured as any of the end portions described above or elsewhere herein.
  • the end portion can be configured to bias the retrieval line to align a tension force applied by said pulling with a central axis of the end portion of the coiled docking device.
  • the methods can include drawing pusher device and/or the end portion of the coiled docking device into a delivery catheter.
  • FIG. 1 shows a schematic cross-sectional view of a human heart
  • FIG. 2 shows a schematic top view of a mitral valve annulus of a heart
  • FIG. 3 shows a perspective view of an exemplary anchor/docking device
  • FIG. 4 shows a side view of the anchor of FIG. 3 ;
  • FIG. 5 shows a top view of the anchor of FIGS. 3 and 4 ;
  • FIG. 6 shows a cross-sectional view of a portion of a heart during a step of delivering the anchor of FIGS. 3 to 5 to the native mitral annulus;
  • FIG. 7 shows a cross-sectional view of a portion of a heart during a further step of delivering the anchor of FIGS. 3 to 5 to the native mitral annulus;
  • FIG. 8 shows a cross-sectional view of a portion of a heart with the anchor of FIGS. 3 to 5 positioned at the native mitral annulus;
  • FIG. 9 shows a cross-sectional view of a portion of a heart with the anchor of FIGS. 3 to 5 and a prosthetic mitral valve implanted at the native mitral annulus;
  • FIG. 10 shows a perspective view of an exemplary anchor/docking device, similar in many respects to the anchor/docking device of FIGS. 3 to 5 ;
  • FIG. 11 schematically shows an open view of an exemplary laser-cut tube that can be used as an anchor/docking device
  • FIG. 11A schematically shows an open view of a laser-cut tube to be used as an anchor and a tensioning wire according to an embodiment of the invention
  • FIG. 12 shows a top view of the laser-cut anchor of FIG. 11 in an assembled state
  • FIG. 13 shows a perspective view of the laser-cut anchor of FIG. 11 in an assembled and actuated state, and with an exemplary frame of a prosthetic valve held therein;
  • FIG. 14 shows a top view of an exemplary anchor/docking device with end hooks
  • FIG. 15 shows a schematic view of another exemplary anchor/docking device with a high friction cover layer
  • FIG. 16 shows a schematic view of yet another exemplary anchor/docking device with friction elements
  • FIG. 16A shows a cross-section view of the embodiment shown in FIG. 16 ;
  • FIG. 17 shows a schematic view of an exemplary anchor/docking device incorporating both a high friction covering and friction elements
  • FIG. 18 shows an exemplary anchor/docking device with surface features to facilitate interlocking or position retention between adjacent coils
  • FIG. 19 shows an exemplary anchor/docking device that is a variation of the anchor of FIG. 10 ;
  • FIG. 19A shows a cross-section view of an exemplary embodiment of the anchor/docking device
  • FIG. 20 schematically shows a top view of an embodiment of an anchor/docking device implanted and arranged at a potential position at the native mitral annulus
  • FIG. 21 shows the anchor of FIG. 19 further including exemplary marker bands
  • FIG. 22 shows a cross-section of an exemplary proximal end of the anchor of FIG. 19 ;
  • FIG. 22A shows an exemplary embodiment of a suture looped through an exemplary anchor/docking device
  • FIG. 22B shows an exemplary embodiment of a suture looped through an exemplary anchor/docking device
  • FIG. 22C shows an exemplary embodiment of a suture looped through an exemplary anchor/docking device
  • FIG. 23 shows an exemplary end of a skeleton or core of an exemplary anchor/docking device
  • FIG. 24 shows an exemplary end of a skeleton or core of an exemplary anchor/docking device
  • FIG. 25 shows an exemplary end of a skeleton or core of an exemplary anchor/docking device
  • FIG. 26 shows an exemplary end of the docking device of FIG. 25 with a cover layer attached over the skeleton or core.
  • FIG. 27A is a perspective view of an exemplary embodiment of an exemplary anchor/docking device having an exemplary spherical tip with an axially aligned retrieval line/suture opening;
  • FIG. 27B is a view showing a cross-section of the spherical proximal tip of FIG. 27A attached to the anchor/docking device;
  • FIG. 27C is a view showing a line/suture looped through the spherical tip of FIGS. 27A and 27B and a delivery device;
  • FIG. 27D is perspective view of the spherical tip of FIG. 27A ;
  • FIG. 27E is a cross-sectional view of the spherical proximal tip of FIG. 27A ;
  • FIG. 27F is an end view of the spherical tip of FIG. 27A ;
  • FIG. 27G is a perspective view of an exemplary embodiment of the spherical tip of FIG. 27A wherein the distal region of the tip is flush with the coiled anchor;
  • FIG. 28A is a perspective view of an exemplary embodiment of an exemplary anchor/docking device having an exemplary spherical tip with an axially aligned retrieval line/suture opening;
  • FIG. 28B is a view showing a cross-section of the spherical proximal tip of FIG. 28A attached to the anchor/docking device;
  • FIG. 28C is a view showing a line/suture looped through the spherical tip of FIGS. 28A and 28B and a delivery device;
  • FIG. 28D is a cross-sectional view of the spherical proximal tip of FIG. 28A ;
  • FIG. 28E is an end view of the spherical tip of FIG. 28A ;
  • FIG. 28F is a perspective view of an exemplary embodiment of the spherical tip of FIG. 28A wherein the distal portion of the tip is flush with the coiled anchor;
  • FIG. 29A is a perspective view of an exemplary anchor/docking device having an exemplary looped tip
  • FIG. 29B is a side view of a line/suture looped through the looped through the tip of FIG. 29A ;
  • FIG. 29C shows the tip of FIG. 29A in pre-folded state
  • FIG. 29D is an end view of the pre-folded tip of Fit. 29 C;
  • FIG. 29E is a top perspective view of the looped proximal tip of FIG. 29A ;
  • FIG. 30A is a perspective view of an exemplary anchor/docking device end with a recessed groove in the proximal end and a connection line/suture;
  • FIG. 30B is a side view of a retrieval line/suture connected with the connection line/suture in the recessed groove of the exemplary anchor/docking device of FIG. 30A .
  • anchors or docking devices e.g., coiled anchors or docking devices
  • TSV expandable transcatheter heart valves
  • a native valve annulus e.g., mitral or tricuspid valve annulus
  • Anchoring/docking devices provide or form a more circular and/or stable annulus at the implant site, in which prosthetic valves having circular or cylindrically-shaped valve frames or stents can be expanded or otherwise implanted.
  • the anchoring/docking devices can be sized and shaped to cinch or draw the native valve (e.g., mitral, tricuspid, etc.) anatomy radially inwards.
  • native valve e.g., mitral, tricuspid, etc.
  • one of the main causes of valve regurgitation e.g., functional mitral regurgitation
  • specifically enlargement of the heart e.g., left ventricle
  • valve annulus e.g., left ventricle
  • stretching out of the native valve (e.g., mitral) annulus can be at least partially offset or counteracted.
  • Some embodiments of the anchoring or docking devices further include features which, for example, are shaped and/or modified to better hold a position or shape of the docking device during and/or after expansion of a prosthetic valve therein.
  • replacement valves can be more securely implanted and held at various valve annuluses, including at the mitral annulus which does not have a naturally circular cross-section.
  • FIGS. 3 to 5 An exemplary anchor/docking device is shown in FIGS. 3 to 5 .
  • FIG. 3 shows a perspective view of the anchor or docking device 1
  • FIG. 4 shows a side view of the anchor/docking device 1
  • FIG. 5 shows a top view of the anchor/docking device 1 .
  • the anchor/docking device can be coiled (e.g., include a coil-shaped portion) as depicted in the figures.
  • the docking device 1 includes a coil with a plurality of turns extending along a central axis of the docking device 1 .
  • the coil can be continuous and can extend generally helically, with various differently sized and shaped sections, as described in greater detail below.
  • the docking device 1 shown in FIGS. 3 to 5 is configured to best fit at the mitral position, but can be shaped similarly or differently in other embodiments for better accommodation at other native valve positions as well.
  • the docking device 1 includes a central region 10 with approximately three full coil turns having substantially equal inner diameters.
  • the central region 10 of the docking device 1 serves as the main landing region or holding region for holding the expandable prosthetic valve or THV when the docking device 1 and the valve prosthesis are implanted into a patient's body.
  • Other embodiments of the docking device 1 can have a central region 10 with more or less than three coil turns, depending for example, on the patient's anatomy, the amount of vertical contact desired between the docking device 1 and the valve prosthesis (e.g., THV), and/or other factors.
  • the coils of the central region 10 can also be referred to as the “functional coils,” since the properties of these coils contribute the most to the amount of retention force generated between the valve prosthesis, the docking device 1 , and the native mitral leaflets and/or other anatomical structures.
  • a main factor is the number of turns included in the functional coils, while other factors include, for example, an inner diameter of the functional coils, a friction force between the coils and the prosthetic valve, and the strength of the prosthetic valve and the radial force the valve applies on the coil.
  • a docking device can have a variety of numbers of coil turns. The number of functional turns can be in ranges from just over a half turn to 5 turns, or one full turn to 5 turns, or more. In one embodiment with three full turns, an additional one-half turn is included in the ventricular portion of the docking device. In another embodiment, there can be three full turns total in the docking device.
  • the atrial portion of the docking device there can be one-half to three-fourths turn or one-half to three-fourths of a circle. While a range of turns is provided, as the number of turns in a docking device is decreased, the dimensions and/or materials of the coil and/or the wire that the coil is made from can also change to maintain a proper retention force. For example, the diameter of the wire can be larger and/or the diameter of the function coil turn(s) in a docking device with fewer coils. There can be a plurality of coils in the atrium and in the ventricle.
  • a size of the functional coils or coils of the central region 10 is generally selected based on the size of the desired THV to be implanted into the patient.
  • the inner diameter of the functional coils/turns e.g., of the coils/turns of the central region 10 of the docking device 1
  • the retention force needed for adequate implantation of a prosthetic valve varies based on the size of the prosthetic valve and on the ability of the assembly to handle mitral pressures of approximately 180 mm Hg.
  • a retention force of at least 18.5 N is needed between the docking device and the prosthetic valve in order to securely hold the prosthetic valve in the docking device and to resist or prevent mitral regurgitation or leakage.
  • a target average retention force should be substantially greater, for example, approximately 30 N.
  • the retention force between the docking device and the valve prosthesis reduces dramatically when a difference between the outer diameter of the prosthetic valve in its expanded state and the inner diameter of the functional coils is less than about 5 mm, since the reduced size differential would be too small to create sufficient retention force between the components.
  • a prosthetic valve with a 29 mm expanded outer diameter is expanded in a set of coils with a 24 mm inner diameter
  • the retention force observed is about 30 N
  • the same prosthetic valve is expanded in a set of coils with a 25 mm inner diameter (e.g., only 1 mm larger)
  • the retention force observed drops significantly to only 20 N.
  • the inner diameter of the functional coils (e.g., the coils of the central region 10 of docking device 1 ) should be 24 mm or less.
  • the inner diameter of the functional coils (e.g., central region 10 of the docking device 1 ) should be selected to be at least about 5 mm less than the prosthetic valve that is selected for implantation, though other features and/or characteristics (e.g., friction enhancing features, material characteristics, etc.) can be used to provide better retention if other sizes or size ranges are used, as various factors can affect retention force.
  • a size of the inner diameter of the functional coils or central region 10 can also be selected to draw the mitral anatomy closer together, in order to at least partially offset or counteract mitral regurgitation that is caused by stretching out of the native valve annulus as a result of, for example, left ventricular enlargement.
  • the desired retention forces discussed above are applicable to embodiments for mitral valve replacements. Therefore, other embodiments of the docking device that are used for replacement of other valves can have different size relationships based on the desired retention forces for valve replacement at those respective positions.
  • the size differentials can also vary, for example, based on the materials used for the valve and/or the docking device, whether there are any other features to prevent expansion of the functional coils or to enhance friction/locking, and/or based on various other factors.
  • the docking device 1 can first be advanced and delivered to the native mitral valve annulus, and then set at a desired position, prior to implantation of the THV.
  • the docking device 1 is flexible and/or made of a shape memory material, so that the coils of the docking device 1 can be straightened for delivery via a transcatheter approach as well.
  • the coil can be made of another biocompatible material, such as stainless steel.
  • the docking device 1 can be delivered to the mitral position transatrially from the left atrium, transseptally through the atrial septum, or can be delivered to the mitral position via one of various other known access points or procedures.
  • FIGS. 6 and 7 illustrate some steps during delivery of a docking device 1 to the mitral position using a transseptal approach, where a guide sheath 1000 is advanced through vasculature to the right atrium and through the atrial septum of the heart to the left atrium, and a delivery catheter 1010 is advanced through the guide sheath 1000 passing through the vasculature, right atrium, and septum into the left atrium. As can best be seen in FIG.
  • the docking device 1 can be advanced through a distal end of the delivery catheter 1010 positioned in the left atrium (e.g., positioned at a commissure), through the native mitral annulus, for example, at a commissure of the native mitral valve, and into the left ventricle.
  • the distal end of the docking device 1 then circles around the mitral anatomy (e.g., native mitral leaflets and/or the chordae tendineae) located in the left ventricle, so that all or at least some of the native leaflets and/or the chordae tendineae are corralled or gathered by and held in (e.g., encircled by) the coils of the docking device 1 .
  • mitral anatomy e.g., native mitral leaflets and/or the chordae tendineae
  • the central region 10 of the docking device 1 are kept relatively small in diameter (e.g., the central region 10 in one embodiment can have an inner diameter of approximately 24 mm (e.g., ⁇ 2 mm) or another diameter smaller than the THV and/or the native annulus) in order to increase retention force with the prosthetic valve, it might be difficult to advance the docking device 1 around the existing leaflets and/or chordae to a desired position relative to the native mitral annulus. This is especially true, if the entire docking device 1 is made to have the same small diameter as the central region 10 . Therefore, referring back to FIGS.
  • the docking device 1 can have a distal or lower region 20 that makes up a leading coil/turn (or leading ventricular coil/turn) of the docking device 1 , which has a diameter that is greater than the diameter of the functional coils/turns or of the coils/turns of central region 10 .
  • the diameter or width of the leading coil/turn (e.g., ventricular coil/turn) of the lower region 20 can therefore be selected to be larger to more easily navigate a distal or leading tip 21 of the docking device 1 around and encircle the features of the mitral anatomy (e.g., leaflets and/or chordae tendineae).
  • the diameter could be any size from 25 mm to 75 mm.
  • diameter does not require that a coil/turn be a complete or perfectly-shaped circle, but is generally used to refer to a greatest width across opposing points of the coil/turn.
  • diameter can be measured from the distal tip 21 to the opposite side, as if the distal lower region 20 or leading coil/turn formed a complete rotation, or the diameter can be considered double a radius of curvature of the leading coil/turn.
  • the lower region 20 of the docking device 1 (e.g., the leading coil/turn) has a diameter (e.g.,) of approximately 43 mm (e.g., ⁇ 2 mm), in other words the radius of curvature at the leading coil/turn can be approximately 21.5 mm.
  • a leading coil/turn with a larger size than the functional coils can help more easily guide the coils around and/or through the chordae geometry, and most importantly, adequately around both native leaflets of the mitral valve.
  • the remaining coils of the docking device 1 can also be guided around the same features, where the reduced size of the other coils can cause the corralled anatomical features to be pulled slightly radially inwardly.
  • the length of the enlarged lower region 20 is generally kept relatively short, to prevent or avoid obstruction or interference of the flow of blood along the left ventricular outflow tract by the lower region 20 .
  • the enlarged lower region 20 extends for only about half a loop or rotation.
  • the lower region 20 when a prosthetic valve is expanded into the docking device 1 and the coils of the docking device 1 start to unwind slightly due to the size differential between the docking device and the prosthetic valve, the lower region 20 may also be drawn in and shift slightly. Under this example, after expansion of the prosthetic valve, the lower region 20 can be similar in size and be aligned substantially with the functional coils of the docking device 1 , rather than continuing to project away from the functional coils, thereby reducing any potential flow disturbances.
  • Other docking device embodiments can have lower regions that are longer or shorter, depending on the particular application.
  • the docking device 1 in FIGS. 3 to 5 also includes an enlarged proximal or upper region 30 that makes up a stabilizing coil/turn (e.g., which can be an atrial coil/turn) of the docking device 1 .
  • a stabilizing coil/turn e.g., which can be an atrial coil/turn
  • the entire docking device 1 is released from the delivery catheter 1010 , and thereafter a prosthetic valve (e.g., a THV) is delivered to the docking device 1 .
  • a prosthetic valve e.g., a THV
  • the coil could be shifted and/or dislodged from its desired position or orientation, for example, by regular heart function. Shifting of the docking device 1 could potentially lead to a less secure implantation, misalignment, and/or other positioning issues for the prosthetic valve.
  • a stabilization feature or coil can be used to help stabilize the docking device in the desired position.
  • the docking device 1 can include the upper region 30 with an enlarged stabilization coil/turn (e.g., an enlarged atrial coil/turn) intended to be positioned in the circulatory system (e.g.
  • the proximal or upper region 30 or stabilization coil/turn can be configured to abut or push against the walls of the circulatory system (e.g., against the walls of the left atrium), in order to improve the ability of the docking device 1 to stay in its desired position prior to the implantation of the prosthetic valve.
  • the stabilization coil/turn (e.g., atrial coil/turn) at the upper region 30 of the docking device 1 in the embodiment shown extends for about or nearly one full turn or rotation, and terminates at a proximal tip 31 .
  • the stabilization coil/turn e.g., atrial coil
  • the radial size of the stabilization coil/turn (e.g., atrial coil) at the upper region 30 can also be significantly larger than the size of the functional coils in the central region 10 , so that the stabilization coil/turn (e.g., atrial coil) flares or extends sufficiently outwardly in order to make contact with the walls of the circulatory system (e.g., the walls of the left atrium).
  • a major diameter 32 or width of the upper region 30 is approximately 50 mm (e.g., ⁇ 2 mm), or about twice as large as the coils in the central region 10 .
  • a bottom region of the left atrium generally narrows towards the native mitral annulus.
  • the stabilization coil/turn e.g., atrial coil
  • the stabilization coil/turn e.g., atrial coil
  • the stabilization coil/turn e.g., atrial coil
  • the force generated between the functional coils and prosthetic valve is sufficient to secure and stabilize the docking device and prosthetic valve without needing the stabilization coil/turn.
  • the stabilization coil/turn (e.g., atrial coil) of the upper region 30 can be non-circular in shape, and in the embodiment shown, is biased and arranged in an elliptical or ovoid shape.
  • an elliptical or other non-circular shape stabilization coil/turn e.g., atrial coil
  • the widths/diameters can be chosen based on the size of the anatomy of a portion of a circulatory system (e.g., based on the size of human's left atrium).
  • the major axis diameter (or greatest width), D1 can range from 40 to 100 mm, or can be from 40-80, mm, or from 40-75 mm.
  • the minor axis diameter (or smallest width) D2 can range from 20 to 80 mm, or from 20 to 75 mm.
  • a major diameter/width D1 of the stabilization coil/turn e.g., atrial coil
  • a diameter/width D2 along a minor axis of the stabilization coil/turn can be much smaller, for example, only slightly larger than the diameter of the central region 10 of the docking device 1 , as can best be seen in the top view of the docking device 1 in FIG. 5 .
  • the biasing of the upper region of the docking device can be effected in other ways.
  • the stabilization coil/turn (e.g., atrial coil) of the upper region 30 can still be substantially circular, and/or the stabilization coil/turn can be biased in one direction, such that a center of the upper region is offset from the center of other portions of the docking device.
  • This biasing of the shape of the upper region 30 of the docking device 1 can, for example, increase contact between the docking device 1 and the wall of the left atrium or other anatomy in the radial direction that the upper region 30 extends farthest from other portions of the docking device 1 .
  • the stabilization coil/turn e.g., atrial coil
  • the stabilization coil/turn can be biased such that when viewed from a bird's eye view ( FIG.
  • the stabilization coil/turn (e.g., atrial coil) has a center that is off center from the center of the functional coils by about 50 to 75% of the diameter of the functional turns.
  • the stabilization turn (e.g., atrial turn) of the coil can be compliant, and flex inwards. This accommodates anatomy (e.g., left atrium anatomy) where the stabilization coil/turn (e.g., atrial coil) may have a major or minor axis diameter that is larger than the atrium or other anatomy itself.
  • the docking device 1 can be rotated or otherwise oriented so that the narrower portion of the upper region 30 , or the portion that extends the least radially outwardly, is directed in an optimal way. For example, when implanted in a native mitral valve, towards the wall of the left atrium that opposes or pushes against the left ventricular outflow tract, so that the amount of pressure applied by the docking device 1 against that portion of the atrial wall is reduced. In this manner, an amount of displacement of that portion of the wall into the left ventricular outflow tract will also be reduced, and the enlarged upper region 30 can therefore avoid obstructing, interfering with, or otherwise affecting the blood flow through the left ventricular outflow tract.
  • the docking device 1 can be more securely held or retained at a proper positioning and orientation at the native valve annulus (e.g., native mitral annulus) before the THV is implanted and expanded therein.
  • the native valve annulus e.g., native mitral annulus
  • Such self-retention of the docking device 1 will more effectively prevent undesirable shifting or tilting of the docking device 1 before the prosthetic valve is fully implanted, thereby improving performance of the implant as a whole.
  • FIGS. 6 to 9 show some of the steps that can be used for delivering and implanting a docking device (e.g., docking device 1 or other docking devices described elsewhere herein) and a THV at the mitral position. While these focus on the mitral position, similar steps can be used in other valve locations, e.g., at the tricuspid valve position.
  • the docking device can be the docking device 1 described above with respect to FIGS.
  • the THV is generally a self-expandable, a mechanically expandable or a balloon expandable THV (or a combination of these) with a circular or cylindrical valve frame or stent that is sized to be expanded and held in the docking device.
  • FIGS. 6 and 7 show a transseptal procedure for delivering the docking device 1 to a patient's mitral position, where a guide sheath/introducer 1000 is advanced across the atrial septum of the heart and a distal end of a delivery catheter 1010 is advanced through the guide sheath 1000 and positioned with a distal opening of the delivery catheter positioned in the left atrium for delivering the docking device 1 .
  • a delivery catheter can be similarly advanced through the anatomy (e.g., vasculature, chambers of the hearth, septum, etc.) and similarly positioned without first inserting or using a guide sheath.
  • the guide sheath 1000 (and/or delivery catheter 1010 ) is introduced into the patient's venous system by percutaneous puncture or by a small surgical cut, for example, at the patient's groin, and then the guide sheath 1000 (and/or catheter 1010 ) is advanced through the patient's vasculature to the left atrium as shown in FIGS. 6 and 7 .
  • the transseptal procedure illustrated is only one example, and various alternative procedures and/or access sites can instead be used for delivering the docking device 1 and/or a suitable prosthetic valve to either the mitral position or to other positions of the heart.
  • a transatrial or transseptal procedure may be preferable, because such procedures provide a cleaner entry into the left side of the heart when compared, for example, to a transapical procedure or other procedure where access to the mitral valve is via the left ventricle, so that the practitioner can avoid direct interference with the chordae tendineae and other ventricular obstacles.
  • the delivery catheter 1010 is advanced to a position in the left atrium where the distal end of the delivery catheter 1010 is just above a plane of the native valve (e.g., the mitral plane) and can be positioned, for example, near a commissure of the native valve.
  • the delivery catheter can be steerable in multiple dimensions (e.g., more than two dimensions) to allow more precise positioning.
  • the positioning of the distal opening of the delivery catheter defines an access site for implanting the docking device 1 at the mitral position.
  • the access site is usually near one of the two commissures of the native mitral valve, so that the leading tip 21 of the docking device 1 can be advanced through the native valve commissure into the left ventricle, in order to deploy the leading coil/turn (e.g., ventricular coil) of the lower region 20 , as well as at least part of the functional coils/turns (e.g., coils/turns of the central region 10 ), into the left ventricle.
  • the leading tip 21 of the docking device 1 is first passed through commissure A3P3 of the native mitral valve, and then more of the docking device 1 is advanced out of the delivery catheter through commissure A3P3.
  • the docking device 1 While the docking device 1 is held in the delivery catheter 1010 , the docking device 1 can be straightened to be more easily maneuvered through the delivery catheter 1010 . Thereafter, as the docking device 1 is rotated, pushed or otherwise advanced out of the delivery catheter 1010 , the docking device 1 can return to its original coiled or curved shape, and further advancement of the docking device 1 out of the delivery catheter causes either a clockwise or a counter-clockwise (i.e., viewing the annulus in the direction of blood outflow) advancement of the leading tip 21 around (e.g., to encircle) various features of the mitral anatomy, based on the direction of curvature of the docking device 1 when it exits the delivery catheter.
  • a clockwise or a counter-clockwise i.e., viewing the annulus in the direction of blood outflow
  • the enlarged leading coil/turn (e.g., ventricular coil/turn) at the lower region 20 of the docking device 1 makes navigating the leading tip 21 of the docking device 1 around the mitral anatomy in the left ventricle easier.
  • the docking device 1 can first go around and corral the posterior leaflet of the native mitral valve.
  • Alternative methods are also available for corralling the posterior leaflet first, for example, by inserting the leading tip 21 through commissure A1P1 and then advancing the docking device counter-clockwise.
  • corralling of the posterior leaflet of the native mitral valve first may be easier than corralling of the anterior leaflet first, because the posterior leaflet is positioned closer to a ventricular wall that provides for a more confined space along which the leading tip 21 can advance.
  • the leading tip 21 of the docking device 1 can therefore use the ventricular wall near the posterior leaflet as a pathway or guide for advancement around the posterior leaflet.
  • there is no ventricular wall nearby that can facilitate or guide the advancement of the leading tip 21 in that direction. Therefore, in some situations, it can be more difficult to properly initiate the encircling of the mitral anatomy when navigating the leading tip 21 to try to first capture the anterior leaflet instead of the posterior leaflet.
  • a docking device can be configured with coils/turns that spiral or rotate in an opposite, counter-clockwise direction (e.g., as seen in FIG. 10 below), where the delivery catheter 1010 also winds in a counter-clockwise direction.
  • such a docking device can be advanced, for example, through commissure A3P3 and into the left ventricle in a counter-clockwise direction viewing the annulus in an outflow (e.g., atrium to ventricle) direction instead of in the clockwise direction described above.
  • outflow e.g., atrium to ventricle
  • an amount of the docking device to be advanced into the left ventricle depends on the particular application or procedure.
  • the coil/turns(s) of the lower region 20 , and most of the coils/turns of the central region 10 (even if not all) are advanced and positioned in the left ventricle.
  • all of the coils/turns of the central region 10 are advanced into the left ventricle.
  • the docking device 1 is advanced to a position where the leading tip 21 sits behind the anterior medial papillary muscle. This position provides a more secure anchoring of the leading tip 21 , and consequently of the docking device 1 as a whole, because the leading tip 21 sits and is held between the chordae tendineae and the ventricular wall in that area.
  • the docking device 1 serves to gather the captured chordae and or leaflets within the coils of the docking device 1 .
  • Both the secure positioning of the leading tip 21 and the holding of the native mitral anatomy by the docking device 1 can serve to prevent obstruction of the left ventricular outflow tract (e.g., of the aortic valve) prior to implantation of the THV.
  • FIG. 7 shows one method of releasing the atrial portion of the docking device 1 into the left atrium.
  • the distal end of the delivery catheter 1010 is rotated backwards or retracted, while the docking device 1 remains in substantially the same position and orientation, until the entire docking device 1 is released from the delivery catheter 1010 .
  • the distal end of the delivery catheter 1010 can thereafter be rotated counter-clockwise or retracted for releasing the atrial portion of the docking device 1 .
  • a ventricular position of the docking device 1 does not have to be adjusted or readjusted during or after releasing the atrial portion of the docking device 1 from the delivery catheter 1010 .
  • Various other methods of releasing the atrial portion of the docking device 1 can also be employed.
  • the stabilization coil/turn e.g., atrial coil
  • it can be held in place and/or retracted/retrieved by a holding device/anchor (e.g., by being hooked to a release/retrieval line, connected by a barb, a Velcro hook, a latch, a lock, an anchor that can screw in to the delivery device, etc.).
  • the docking device is not tightly engaged with the native mitral valve (i.e., it is only loosely positioned around the native mitral valve leaflets).
  • the delivery catheter 1010 can be removed to make room for a separate delivery catheter for delivering the THV, or in some embodiments, the delivery catheter 1010 can be adjusted and/or repositioned if the prosthetic valve is to be delivered through the same catheter 1010 .
  • the guide sheath 1000 can be left in place and the prosthetic valve or THV delivery catheter can be inserted and advanced through the same guide sheath 1000 after the delivery catheter 1010 is removed.
  • FIG. 8 shows a cross-sectional view of a portion of a patient's heart with the docking device 1 of FIGS. 3 to 5 positioned at the mitral position and prior to delivery of the THV.
  • the enlarged upper region 30 of the docking device 1 can push against the atrial walls to help hold the docking device 1 in the desired orientation, and as described above, the biasing of the upper region 30 can be arranged so that the upper region 30 does not push against any walls that could potentially lead to obstructions in the left ventricular outflow tract.
  • the native mitral valve can still continue to operate substantially normally, and the patient can remain stable, since the valve leaflets are not substantially restrained by the docking device. Therefore, the procedure can be performed on a beating heart without the need for a heart-lung machine. Furthermore, this allows the practitioner more time flexibility to implant the valve prosthesis, without the risk of the patient being in or falling into a position of hemodynamic compromise if too much time passes between the implantation of the docking device 1 and the later valve implantation.
  • FIG. 9 shows a cross-sectional view of a portion of the heart with both the docking device 1 and a prosthetic valve 40 (e.g., THV) finally implanted at the mitral position.
  • the prosthetic valve 40 will have an expandable frame structure 41 that houses a plurality of valve leaflets 42 .
  • the expandable frame 41 of the prosthetic valve 40 can be balloon expandable, or can be expanded in other ways, for example, the frame can be self-expanding, mechanically-expanding, or expandable in a combination of ways.
  • the prosthetic valve 40 can be delivered through the same catheter 1010 used to deliver the docking device 1 , or can be introduced through a separate catheter, generally while the valve 40 is radially collapsed for easier navigation through the delivery catheter.
  • the guide sheath can be left in place when catheter 1010 is removed, and a new prosthetic valve or THV delivery catheter can be advanced through guide sheath 1000 .
  • the prosthetic valve 40 is then advanced out of the delivery catheter and positioned through the docking device 1 while still in the collapsed configuration, and can then be expanded in the docking device 1 , so that the radial pressure or tension between the components securely hold the entire assembly in place at the mitral position.
  • the mitral valve leaflets (or a portion of the mitral valve leaflets) can be sandwiched between the functional turns of the anchor or docking coil and the frame 41 of the prosthetic valve. After the docking device and prosthetic valve are securely deployed/implanted, the remaining delivery tools can be removed from the patient.
  • FIG. 10 shows a perspective view of an exemplary anchor or docking device 1 .
  • the docking device 100 in FIG. 10 has a central region 110 , a lower region 120 , and an upper region 130 that can be the same as or similar to the respective central, lower, and upper regions 10 , 20 , 30 in the previously described docking device 1 .
  • the docking device 100 can include features and characteristics that are the same as or similar to features and characteristics described with respect to docking device 1 , and can also be implanted using the same or similar steps.
  • the docking device 100 includes an additional extension 140 substantially positioned between the central region 110 and upper region 130 .
  • the extension 140 can optionally be positioned, for example, wholly in the central region 110 (e.g., at an upper portion of the central region 110 ) or wholly in the upper region 130 .
  • the extension 140 is made up of or includes a vertical part of the coil that extends substantially parallel to a central axis of the docking device 100 .
  • the extension 140 can be angled relative to the central axis of the docking device 100 , but will generally serve as a vertical or axial spacer that spaces apart the adjacent connected portions of the docking device 100 in a vertical or axial direction, so that a vertical or axial gap is formed between the coil portions on either side of the extension 140 (e.g., a gap can be formed between an upper or atrial side and a lower or ventricular side of the docking device 100 ).
  • the extension 140 of the docking device 100 is intended to be positioned through (e.g., crossing) or near the native valve annulus, in order to reduce the amount of the docking device 100 that passes through or pushes or rests against the native annulus when the docking device 100 is implanted. This could potentially reduce the stress or strain applied by the docking device 100 on the native mitral valve.
  • the extension 140 is positioned at and passes through or crosses at one of the commissures of the native mitral valve. In this manner, the extension 140 can space the upper region 130 apart from native mitral leaflets to prevent the upper region 130 from interacting with or engaging the native leaflets from the atrial side.
  • the extension 140 also raises a position of the upper region 130 , so that the contact that the upper region 130 makes against the atrial wall can be elevated or spaced farther away from the native valve, which could, for example, also reduce stresses on and around the native valve, as well as provide for a more secure holding of the position of the docking device 100 .
  • the extension 140 can have a length ranging from 5 to 100 mm, and in one embodiment is 15 mm.
  • the docking device 100 can further include one or more through holes 150 at or near one or both of the proximal and distal ends of the docking device 100 .
  • the through holes 150 can serve, for example, as suturing holes for attaching a cover layer over the coil of the docking device 100 , and/or for example, as an attachment site for delivery tools, such as a pull wire/suture for a pusher, a holding device/anchor (e.g., for holding the docking device and/or allowing retraction and retrievability of the device after being fully or partially deployed from the delivery catheter), or other advancement device or retention device.
  • a width or thickness of the coil of the docking device 100 can also be varied along the length of the docking device 100 .
  • a central region of the docking device 100 can be made slightly thinner than end regions of the docking device 100 (not shown), so that for example, the central regions exhibit greater flexibility, the end regions are stronger or more robust, and/or the end regions provide more surface area for suturing or otherwise attaching a cover layer to the coil of the docking device 100 , among other reasons.
  • all or a portion of extension 140 can have a thickness that is less than the thickness in other regions of the docking device, e.g., extension 140 can be thinner than the leading coil/turn or lower region 120 , thinner than the functional coils/turns or central region 110 , and/or thinner than the stabilization coil/turn or upper region 130 , e.g., as shown, for example, in FIG. 19 .
  • the coils of the docking device 100 are depicted as turning in a direction opposite to the coils in the docking device 1 described above. Therefore, the docking device 100 , as depicted, is configured to be inserted through the native valve annulus in a counter-clockwise direction viewing the annulus in the direction of blood outflow (e.g., from atrium to ventricle). This advancement can be made through commissure A3P3, commissure A1P1, or through another part of the native mitral valve.
  • Arrangement of the docking device 100 in a counter-clockwise direction also allows for bending of the distal end of the delivery catheter in a similar counter-clockwise direction, which in many instances is easier to achieve than to bend the delivery catheter in the clockwise direction.
  • the various anchor/docking device embodiments described herein can be configured for either clockwise or counter-clockwise advancement through one of various access points (e.g., either commissure).
  • the docking device should be placed high relative to the native mitral valve (e.g., farther into the left atrium).
  • the finally implanted dock and valve combination should be placed high at the native valve, in some cases as high as possible, to anchor the valve to a clear zone of the native mitral leaflets.
  • the native mitral leaflets are generally smoother above the coaptation line (e.g., above where the leaflets come together when the mitral valve is closed) and rougher below the coaptation line.
  • the smoother area or zone of the native leaflets are much more collagenous and stronger, thereby providing a more secure anchoring surface for the prosthetic valve than the rougher area or zone.
  • the docking device should be placed as high as possible at the native valve during insertion, while also having sufficient retention force to anchor the prosthetic valve or THV.
  • the length of the coil in the docking device placed in the ventricle generally depends on the number of turns in the ventricle and the thickness of the wire used. Generally, the thinner the wire used, the more length is required in the ventricle to provide sufficient retention force. For example, if a docking device coil has a length of 370 mm, then about 280 mm (e.g., ⁇ 2 mm) would be placed in the ventricle. About 70 to 90 mm would be placed in the atrium, and about 10-15 would be used in the transition or extension length to move the docking device coils away from the plane of the mitral valve on the atrial side of the docking device.
  • the average mitral valve in humans measures approximately 50 mm along its long axis and 38 mm along its short axis. Due to the size and shape of the native valve and the typically smaller size of replacement valves, an inverse relationship is formed with respect to the coil diameter of the docking device between how high the docking device can be placed at the mitral position and the retention force the docking device can provide for the THV to be implanted therein. Docking devices with larger diameters are able to capture more chordae therein and consequently have the ability to be deployed higher relative to the native valve, but will provide a lower amount of retention force for valves that are docked in them.
  • docking devices with smaller diameters can provide stronger retention forces for docked valves, but may not be able to go around and capture as many chordae during positioning, which can result in lower positioning of the docking device in the native valve annulus.
  • larger docking devices can be modified so that they have increased coil diameters or thicknesses and/or can be constructed using materials with higher moduli of elasticity.
  • FIGS. 11 to 13 show a docking device according to another embodiment of the invention.
  • the docking device 200 (see FIGS. 12 and 13 ) is formed with a laser-cut tube 210 and a tensioning wire 219 .
  • the wire 219 can be used to adjust the curvature and/or size of the docking device 200 .
  • the docking device 200 can assume a larger or wider configuration when being positioned at the native valve annulus, and can thereafter be adjusted with the wire 219 to assume a smaller or narrower configuration to prepare for docking a prosthetic valve.
  • FIG. 11 schematically shows an open sheet view of a laser-cut tube 210 , e.g., the ends of the sheet can be connected to form a tubular structure, or a similar tube can be formed as a tube and cut as a tube, i.e., without a seam.
  • the tube 210 can be made from either shape memory or non-shape memory material (e.g., NiTi, stainless steel, other materials, or a combination of materials).
  • the tube 210 can be laser cut with the pattern shown in FIG. 11 , or with a similar pattern, where the cutting pattern dictates the shape of the docking device 200 when the docking device 200 is actuated. The patterned cuts in FIG.
  • each of the cuts 211 can further form one or more teeth 213 and one or more corresponding grooves 214 in adjacent links 212 , where the teeth 213 can extend into the adjacent grooves 214 , including when the tube 210 is bent or curved.
  • the teeth 213 and grooves 214 formed by each cut 211 can extend in a same direction along the tube 210 , or some can be configured to extend in the opposite direction, depending on the desired shape of the docking device 200 .
  • each of the cuts 211 further include end regions 215 on either end of the cuts 211 that extend parallel to the longitudinal axis of the tube 210 .
  • the end regions 215 provide space for adjacent links 212 to pivot relative to one another while remaining interconnected.
  • the laser-cut patterning can also be modified or varied along the length of the tube 210 , with cuts having different sizes, shapes, and positioning on the sheet or tube, in order to effect different shapes and curvatures in the docking device 200 when the docking device 200 is tensioned or actuated.
  • a left end of the sheet or tube includes other cuts 216 that are larger than cuts 211 that are found at the central and right portions of the sheet or tube (as illustrated).
  • the left end of the tube 210 can have such enlarged laser cut patterns in order to effect a more mobile or flexible distal tip of the docking device 200 , as described in greater detail below.
  • the laser-cut sheet or tube can include one or more distal wire lock features, for example, cut 217 at a distal or left end of the sheet or tube as illustrated, and/or one or more proximal wire lock features, for example, cuts 218 at the proximal or right end of the sheet or tube as illustrated.
  • a locking wire 219 illustrated in FIG. 11A , can be attached to the distal or proximal end of the tube 210 , and can then be tensioned through the tube 210 and locked at the opposite end of the tube 210 in order to effect a desired actuated shape of the docking device 200 .
  • the tube 210 By having laser cut patterns positioned along a large portion of or along the entire length of the tube 210 , when the locking wire 219 is attached at one end of the tube 210 and is then actuated and locked to the other end of the tube 210 , the tube 210 is forced into a desired final coil form or shape by virtue of the arrangement of the cuts 211 and 216 .
  • the tension in the tensioning wire has the ability to control the radial outward and inward forces applied onto the docking device 200 , and by the docking device 200 onto other features, for example, on a replacement valve 40 held therein.
  • the locking wire can assist in controlling the forces applied by the docking device, but in other embodiments, a locking wire is not required.
  • the locking wire can be in a laser-cut hypotube, or the locking wire can be in a tube that is not laser cut.
  • the locking wire can be a suture, tether, wire, strip, etc., and the locking wire can be made of a variety of materials, e.g., metal, steel, NiTi, polymer, fiber, Dyneema, other biocompatible materials, etc.
  • the tube 210 can be placed around a round mandrel defining a desired coil diameter during manufacture and shape set at that specific diameter.
  • the shape set diameter can in some embodiments be larger than the desired final diameter of the docking device 200 , so that the tube 210 assumes the larger shape set diameter when it is extruded from a delivery catheter and prior to the locking or tensioning wire being actuated.
  • the larger diameter of the docking device 200 can help assist the docking device 200 in more easily navigating around and encircling the anatomical geometry of the native valve.
  • the distal tip 222 of the tube 210 can be shape set differently, so that instead of following the same coil shape as the rest of the docking device 200 , the distal tip 222 flexes or articulates slightly radially outwardly compared to other portions of the docking device 200 , for example, as can be seen in FIG. 12 , in order to further assist in helping to encircle the mitral anatomy or other valve anatomy.
  • the distal end 222 of the tube 210 can include different cuts 216 in order to make the distal end 222 more flexible or mobile, which can also assist in navigating the distal end 222 of the docking device 200 around the anatomical geometry.
  • the locking wire can be tensioned or otherwise actuated in order to reduce the size of the docking device (e.g., to reduce the diameter of the turns of the coil), in preparation for a tighter or more secure docking of a prosthetic replacement valve 40 .
  • the tensioning of the locking wire can in some cases draw or pull the distal tip 222 further inwards such that the distal tip 222 conforms more closely in shape to the rest of the docking device 200 , to more effectively contribute to the docking of the replacement valve 40 .
  • FIG. 13 is an example of the docking device 200 after it has been actuated by the locking wire, and also after the replacement valve 40 has been expanded therein.
  • the tension in the locking wire helps to more effectively hold a desired shape and size of the docking device 200 and to maintain a stronger retention force between the docking device 200 and the valve 40 .
  • the radial outward pressure provided by the valve 40 on the docking device 200 is countered by the radial inward pressure provided by the tensioning or locking wire and docking device 200 onto the valve 40 , forming a stronger and more secure hold between the pieces.
  • FIG. 13 is an example of the docking device 200 after it has been actuated by the locking wire, and also after the replacement valve 40 has been expanded therein.
  • the tension in the locking wire helps to more effectively hold a desired shape and size of the docking device 200 and to maintain a stronger retention force between the docking device 200 and the valve 40 .
  • the radial outward pressure provided by the valve 40 on the docking device 200 is countered
  • the docking device 200 can more effectively hold its shape and size, the radial inward pressure from the docking device 200 on the valve 40 can cause a flaring effect at the ends of the frame of the valve 40 , thereby providing an even more secure hold between the docking device 200 and the valve 40 .
  • the docking device 200 can be modified in various ways in other embodiments.
  • the docking device can be made from or include shape memory materials other than NiTi, or in some embodiments can be made from non-shape memory materials, such as stainless steel, from other biocompatible materials, and/or a combination of these.
  • shape memory materials other than NiTi
  • non-shape memory materials such as stainless steel
  • a similar or slightly modified docking device can also be used to dock replacement valves at other native valve sites, for example, at the tricuspid valve, pulmonary valve, or at the aortic valve.
  • the docking device 200 described above, and similar devices using a tensioning or locking wire, can provide several advantages over other docking devices, such as devices where a locking wire is not used.
  • the locking wire provides a user with the ability to control an amount of the radial outward and inward forces applied on and by the docking device through effecting and adjusting the tension in the locking wire, without compromising a desired profile of the docking device or the ability to deliver the docking device through a catheter or via minimally invasive techniques.
  • FIG. 11A illustrates a tensioning wire 219 that is held below the teeth 218 or looped around teeth 218 , then pulled through the opening 217 and crimped at the opening 217 to set the shape of the docking device.
  • the laser cuts in the tube make the docking device more flexible, enabling the docking device to be introduced through catheters that may have relatively small bend radii at certain locations.
  • the docking device can be shape set to include a coil/turn having a larger diameter to allow the coil to more easily encircle anatomical features during delivery of the docking device and prior to the locking wire being tensioned.
  • the distal tip of the docking device can further be shape set to flex or bias slightly outwards to help encircle even more of the anatomical geometry during advancement and positioning of the docking device.
  • the distal tip of the docking device can further be modified, for example, with more material removed to form larger cuts, making the distal portion of the docking device even more flexible, so that the tip can more easily be actuated and manipulated to more effectively navigate it around and encircle different cardiovascular anatomies.
  • a pattern can be laser cut to reduce the forces more in one area than another.
  • the tube can be ovalized, that is the cross-section area of the tube can be ovalized, so that the forces allow the tube to curve in a desired direction.
  • the tensioning wire can also be clamped at both a proximal and a distal end of the tube, to provide a tensioning force. Exemplary cut patterns are illustrated, but other cut patterns are also possible.
  • Various mechanisms can further be incorporated or added to one or more of the docking devices described herein (e.g., herein docking devices 1 , 100 , 200 , 300 , 400 , 500 , 600 , and 1100 ), for example, in order to increase the retention force between the docking device and a replacement valve that is expanded therein.
  • coiled or coil-shaped docking devices will have two open or free ends after implantation. When a THV or other replacement valve is expanded in the coil, the coil can partially unwind and increase in diameter due to the outward pressure applied by the expanding valve on the coil, which in turn reduces the retention force applied by the coil on the valve.
  • Mechanisms or other features can therefore be incorporated into the docking devices to prevent or reduce unwinding of the coil when the replacement valve is expanded in it, resulting in an increase in radial forces and retention forces between the docking device and the valve.
  • Such mechanisms can be incorporated in lieu of modifying the size and shape of the docking device, for example, without making the coil thicker or reducing the diameter of the inner space formed by the coil, both of which can negatively affect the performance or ease of delivery of the docking device. For example, when the coil of the docking device itself is made thicker, the increased thickness results in a more rigid coil, making it more difficult to pass the docking device through a delivery catheter. Meanwhile, when the diameter of the inner space formed by the coil is reduced too much, the reduced space can prevent the expandable valve from fully expanding.
  • FIG. 14 A first alternative modification to ensure sufficient retention force between a docking device and a valve that is expanded in the docking device is shown in FIG. 14 .
  • the docking device 300 in FIG. 14 includes a main coil 310 (which can be similar in size and shape to one of the docking devices described above) and anchors 320 extending from the two free ends of the coil 310 .
  • the anchors 320 are sized, shaped, or otherwise configured to embed themselves into the surrounding tissue (e.g., into the atrial and/or ventricular walls), for example, when a replacement valve is expanded in the docking device 300 .
  • the anchors 320 can be barbed to promote ingrowth once the anchors 320 are embedded into the heart walls or other tissue.
  • the anchors can be any of many different shapes and sizes.
  • the anchors can extend from the end or from any area near the end.
  • anchors or barbs can also be positioned at various locations along the length and outer surface of the docking device.
  • the docking device 300 In operation, when the docking device 300 is deployed at the mitral anatomy, once the docking device 300 is positioned through the mitral valve, one end of the docking device 300 is positioned in the left atrium while the other end of the docking device 300 is positioned in the left ventricle.
  • the shape and size of the coil 310 of the docking device 300 can be selected and optimized to ensure that the ends of the coil 310 respectively abut against the atrial and ventricular walls when the docking device 300 is advanced to the desired position.
  • the anchors 320 at the ends of the coil 310 can therefore anchor themselves into the respective heart walls. When the replacement valve is expanded in the coil 310 , the free ends of the coil 310 are held in position by the anchors 320 being lodged in the heart walls.
  • the inability of the free ends of the coil 310 to move when the replacement valve is expanded in the docking device 300 prevents the coil 310 from unwinding, thereby increasing the radial forces applied between the docking device 300 and the expanded valve and improving the retention force between the components.
  • FIG. 15 shows a schematic view of a portion of another modified docking device for improving retention forces between the docking device and a replacement valve. Portions of three turns of a docking device 400 are illustrated in FIG. 15 .
  • the docking device 400 includes a main coil or core 410 , which can be for example, a NiTi coil/core, or a coil/core that is made of or includes one or more of various other biocompatible materials.
  • the docking device 400 further includes a covering 420 that covers the coil/core 410 .
  • the covering 420 can be made of or include a high friction material, so that when the expandable valve is expanded in the docking device 400 , an increased amount of friction is generated between the valve and the covering 420 to hold a shape of the docking device 400 and prevent or inhibit/resist the docking device 400 from unwinding.
  • the covering can also or alternatively increase the amount of friction between the docking device and native leaflets and/or the prosthetic valve to help retain the relative positions of the docking device, leaflets, and/or prosthetic valve.
  • the covering 420 is made from one or more high friction materials that is placed over the coil wire 410 .
  • the covering 420 is made of or includes a PET braid over an ePTFE tube, the latter of which serves as a core for the covering 420 .
  • the ePTFE tube core is porous, providing a cushioned, padded-type layer for struts or other portions of a frame of the expandable valve to dig into, improving engagement between the valve and the docking device 400 .
  • the PET layer provides additional friction against the native valve leaflets when the prosthetic valve is expanded and the struts or other portions of the valve frame apply outward pressure on the docking device 400 .
  • the covering 420 can be made from one or more other high friction materials that covers the coil 410 in a similar manner.
  • the material or materials selected for making the covering 420 can also promote rapid tissue ingrowth.
  • an outer surface of a frame of the replacement valve can also be covered in a cloth material or other high friction material to further increase the friction force between the docking device and the valve, thereby further reducing or preventing the docking device from unwinding.
  • the friction provided by the covering can provide a coefficient of friction greater than 1.
  • the covering can be made of ePTFE and can be a tube that covers the coil, and can be smooth or can have pores (or be braided or have other structural features that provide a larger accessible surface area like pores do) to encourage tissue ingrowth.
  • the covering can also have a PET braid over the ePTFE tube when the ePTFE tube is smooth.
  • the outermost surface of the covering or braid over the covering can be any biocompatible material that provides friction, such as a biocompatible metal, silicone tubing, or PET. Pore size in the covering can range from 30 to 100 microns.
  • the PET layer is only attached to the ePTFE covering, and not directly to the coil of the docking device.
  • the ePTFE tube covering can be attached to the docking device coil at the coverings proximal and distal ends. It can be laser welded on to the coil, or radiopaque markers can be placed on the outside of the ePTFE tube covering or PET braid and swaged to the materials to hold them in place to the coil.
  • the docking device 400 can also include anchors similar to anchors 320 discussed above to further increase retention forces, but other embodiments of the docking device may incorporate the covering 420 without further including any such additional end anchors.
  • the covering 420 can be added to any of the docking devices described herein (e.g., docking devices 1 , 100 , 200 , 300 , 400 , 500 , 600 , and 1100 ) and can cover all or a portion of the docking device.
  • the covering can be configured to only cover the functional coils, the leading coil, the stabilization coil, or just a portion of one or more of these (e.g., just a portion of the functional coils)
  • FIGS. 16 and 16A schematically show a portion of yet another modified docking device that improves retention forces between the docking device and a replacement valve.
  • the valve leaflet tissue 42 undulates to conform to the varying cross-section between the areas of the coil 510 with frictional elements 510 and without the frictional elements. This undulating of the leaflet tissue 42 results in a more secure entrapment of the tissue 42 between the docking device 1 and the valve frame 41 .
  • the docking device 500 in FIG. 16 includes a main coil 510 and one or more discrete friction elements 520 that are spaced apart along a length of the coil 510 .
  • the friction elements 520 can be made from a cloth material or other high friction material, such as PET, and can be formed as small bulges on the surface of the coil 510 or on another layer that is placed on the coil 510 .
  • the covering 420 can itself be considered a frictional element or be configured to form one or more of the frictional elements 520 .
  • the friction elements 520 are added on top of adding a high friction covering 530 that is similar to the covering 420 discussed above.
  • An example of a docking device 500 with both a high friction covering 530 and friction elements 520 applied over a main coil 510 is schematically illustrated in FIG. 17 .
  • friction is formed between the frame of the valve and the friction elements 520 and/or between the frame of the valve, the native valve leaflets, and the docking device that prevents or inhibits/resists the coil 510 of the docking device 500 from unwinding.
  • the friction elements 520 can engage or otherwise extend into cells defined by the frame of the expandable valve and/or force valve leaflet tissue into cells of the expandable valve.
  • each of the friction elements 520 can engage with adjacent turns of the docking device 500 above and/or below the friction element 520 , and/or with one or more other friction elements 520 on the adjacent turns of the docking device 500 . Any or all of these such engagements will cause the docking device 500 to inhibit or resist unwinding, thereby increasing the retention force between the docking device 500 and the expanded valve.
  • FIG. 18 schematically shows parts of three turns of still another modified docking device 600 that helps improve retention forces between the docking device and a replacement valve.
  • the docking device 600 includes a coil 610 that is modified with one or more interlocking lock and key patterns spaced apart along the length of the coil 610 .
  • the lock and key patterns can be simple, for example, a rectangular groove or cutout 618 and a complementary rectangular projection 622 , as generally illustrated in FIG. 18 , or can be made of or include different shapes and/or more complex patterns in other embodiments.
  • the grooves 618 and projections 622 can all be arranged in a same axial direction or in different axial directions in varying embodiments.
  • the lock and key patterns or other frictional elements can be placed on the functional turns of the docking device.
  • the lock and key mechanism When an expandable valve is expanded in the docking device 600 , the lock and key mechanism relies on adjacent turns of the coil 610 abutting against one another and on each turn interlocking with adjacent turns of the coil 610 located above and/or below it when one or more of the projections 622 engage corresponding grooves 618 .
  • the interlocking of the grooves 618 and the projections 622 prevents relative motion between the respective features, consequently also preventing the coil 610 of the docking device 600 from physically unwinding. Therefore, this arrangement also serves to increase the radial forces and the final retention force between the docking device 600 and a replacement valve that is expanded in the docking device 600 .
  • FIG. 19 shows a perspective view of an exemplary anchor or docking device.
  • the docking device 1100 in FIG. 19 can be the same as or similar in structure to the docking device 100 in FIG. 10 described above and can include any of the features and characteristics described with respect to docking device 100 .
  • Docking device 1100 can also include a central region 1110 , a lower region 1120 , an upper region 1130 , and an extension region 1140 .
  • the lower and upper regions 1120 , 1130 can form larger coil diameters than the central region 1110
  • the extension region 1140 can space the upper region 1130 apart from the central region 1110 in a vertical direction, also similarly as previously described.
  • the docking device 1100 is also arranged or wound so that advancement of the docking device 1100 into the left ventricle can be performed in a counter-clockwise manner viewing the annulus in the outflow direction (e.g., from atrium to ventricle). Other embodiments may instead facilitate clockwise advancement and placement of the docking device.
  • the central coils/turns 1110 of the docking device 1100 also serve as the functional coils/turns, and provide a main docking site for a prosthetic valve or THV that is expanded therein.
  • the central turns 1110 will generally be positioned in the left ventricle, while a small distal portion, if any, will extend through the native valve annulus and into the left atrium, described in greater detail below.
  • the central turns 1110 can have an inner diameter ranging from 20 mm to 30 mm, and in an exemplary embodiment can be approximately 23 mm (e.g., ⁇ 2 mm), in order to provide about 16 N of retention force between the parts, which is sufficient for stably holding the expanded THV in the docking device 1100 , and preventing the THV from dislodging from the docking device 1100 , even during severe mitral pressures.
  • the lower region 1120 of the docking device 1100 serves as a leading coil/turn (e.g., a ventricular encircling turn).
  • the lower region 1120 includes the distal tip of the docking device 1100 , and flares radially outwardly from the central turns 1100 , in order to capture the native valve leaflets, and some or all of the chordae and/or other mitral anatomy, when the docking device 1100 is advanced into the left atrium.
  • Native mitral valves exhibiting mitral regurgitation typically measure about a 35 mm A2P2 distance and a 45 mm distance from commissure to commissure.
  • the lower region 1120 is formed to have an enlarged size or profile compared to the central turns 1110 , in order to initially guide the docking device 1100 more easily around both of the native valve leaflets.
  • the diameter of the lower region 1120 can be constructed to be about the same as the distance measured between the commissures of the native valve (e.g., 45 mm), such that the distal tip will extend approximately that distance away from the outlet of the delivery catheter during delivery of the docking device 1100 .
  • the upper region 1130 of the docking device 1100 serves as the stabilization coil/turn (e.g., atrial coil/turn) that provides the docking device 1100 with a self-retention mechanism during the transition phase after the docking device 1100 is deployed at the native valve and prior to delivery of the THV.
  • the left atrium generally flares outwardly from the mitral annulus, forming a funnel-like shape that widens away from the annulus.
  • the diameter of the upper region 1130 is selected to allow the upper region 1130 to fit at an approximate desired height in the left atrium, and to prevent the upper region 1130 from sliding or dropping further towards the native mitral annulus after the desired position is achieved.
  • the upper region 1130 is formed to have a diameter from 40-60 mm, such as a diameter of about 53 mm.
  • FIG. 20 is a schematic top view of a portion of a heart, showing an approximation of the left atrium 1800 , and the mitral valve 1810 positioned at a central region thereof.
  • an approximate position of the aorta 1840 is also schematically illustrated.
  • a docking device 1100 has been delivered to the native mitral valve 1810 at commissure A3P3 1820 .
  • the upper region 1130 of the docking device 1100 is positioned away from a wall 1830 of the left atrium 1800 that is adjacent to the aorta 1840 . Furthermore, when the THV is expanded in the docking device, the central region 1110 of the docking device 1100 will tend to slightly expand and unwind, which can further draw the upper region 1130 away from the atrial wall 1830 (e.g., counter-clockwise and downward as illustrated in FIG. 20 ). Additional details of the positioning of the docking device 1100 relative to the mitral valve 1810 , with further reference to FIG. 20 , will be discussed in greater detail below.
  • the extension region 1140 provides a vertical extension and spacing between the central region 1110 and the upper region 1130 of the docking device 1100 .
  • the extension region 1140 of the docking device 1100 (and extension 140 of docking device 100 ) can therefore be referred to as an ascending turn.
  • the location at which the docking device 1100 crosses the mitral plane is important in preserving the integrity of the native valve anatomy, and specifically the valve leaflets and commissures, to serve as an appropriate docking site for the final implantation of the THV.
  • the extension region 1140 of the docking device 1100 can also have a smaller diameter cross-section.
  • the wire core of other regions of the docking device 1100 can have a diameter of, for example, 0.825 mm, while the core of the extension region 1140 can have a diameter of 0.6 mm.
  • the wire core of other regions of the docking device has a cross section diameter of 0.85 mm, and the extension region has a cross-section diameter of 0.6 mm.
  • the extension region 1140 can have a cross-section diameter of 0.4 to 0.8 mm.
  • the thicknesses can also be chosen based on a ratio to one another.
  • the extension region can have a cross-section diameter that is 50% to 75% of the cross-section diameter of the rest of the portions of the wire.
  • An extension region 1140 with a smaller cross-section can allow for a sharper angle of ascension of the extension region 1140 from the mitral plane.
  • the radius of curvature and the wire cross-section of the extension region 1140 can further be selected, for example, to provide a sufficient connection point between the central region 1110 and the upper region 1130 of the docking device 1100 , and/or to allow the extension region 1140 to be deployed and retrieved more easily with smaller forces during delivery, since a thinner wire core is generally easier to straighten and bend.
  • the thicknesses of both the extension region 1140 and the rest of the docking device 1100 should be chosen so as not to exceed any strain limits, based on the material properties of the material or materials selected.
  • a wire core of the docking device 1100 can be made of NiTi, another shape memory material, or another biocompatible metal or other material, the wire core can be covered by one or more additional materials. These cover or layer materials can be attached in a variety of ways including, for example, adhesion, melting, molding, etc. around the core or otherwise suturing, tying, or binding the cover/layer to the wire core.
  • a cross-section of a distal portion of the docking device 1100 includes a wire core 1160 and a cover layer 1170 .
  • the wire core 1160 for example, can provide strength to the docking device 1100 .
  • a base material of the cover layer 1170 which covers the wire core 1160 can be, for example, ePTFE or another polymer.
  • the cover layer 1170 can be more compressive than the wire core 1160 , so that the wire frame and/or struts of the THV can partially dig into or otherwise anchor into the cover layer 1170 for added stability when the THV is expanded in the docking device 1100 .
  • a more compressible material will also allow the pinching or compression of the native valve leaflets and other anatomy between the docking device 1100 and the THV to be less traumatic, leading to less wear and/or damage to the native anatomy.
  • ePTFE the material is also not water or blood permeable, but will allow ethylene oxide gas to pass or penetrate through, thereby providing a layer through which the underlying wire core 1160 can be more easily sterilized.
  • an ePTFE cover layer 1170 can be constructed with, for example, a 30 micron pore size, to facilitate easy anchoring of blood cells in and against the outer surface of the cover layer 1170 , for example, to promote in-growth of tissue after implantation.
  • ePTFE is also a very low friction material.
  • a docking device 1100 with an ePTFE cover layer 1170 will provide for stability and promote in-growth.
  • FIG. 19A illustrates a cross-section view of the layers.
  • the covering 1180 (depicted as a braided layer) or other high friction layer provides additional friction between adjacent coils and against the native leaflets and/or THV when the THV is expanded in the docking device 1100 .
  • the friction that is formed at the interfaces between coils and between the inner surface of the central region 1110 of the docking device 1100 , the native mitral leaflets, and/or the outer surface of the THV creates a more secure locking mechanism to more strongly anchor the THV and the docking device 1100 to the native valve.
  • the functional coils/turns or central region 1110 of the docking device 1100 is generally the only region where a high friction covering/layer is desired, as seen in FIG. 19 , the braid layer or high friction covering/layer 1180 does not extend into either the lower region 1120 or the extension region 1140 , so that those regions of the docking device 1100 , along with the upper region 1130 , remain low friction, in order to facilitate less traumatic interactions with the native valve and other heart anatomy. Additional friction elements and thus improvement in retention forces between the docking device and a replacement valve, can also be added to the device through any combination of the high friction covering/layer 1180 and high friction elements or other features described herein and illustrated in FIGS. 15-18 .
  • FIG. 20 shows a top view of a possible placement of the docking device 1100 at the native mitral valve 1810 prior to expansion of a THV therein.
  • the docking device 1100 is advanced counterclockwise through commissure A3P3 1820 of mitral valve 1810 and into the left ventricle.
  • the remaining turns of the docking device 1100 is then released from the delivery catheter, for example, by a clockwise or opposite rotation of the delivery catheter, such that these parts of the docking device 1100 can be unsheathed or otherwise released while a position of the central region 1110 and the lower region 1120 of the docking device 1100 remains stationary or substantially in position relative to the surrounding anatomy.
  • a desired amount of the docking device 1100 e.g., the lower region 1120 and much of the central region 1110
  • the remaining turns of the docking device 1100 is then released from the delivery catheter, for example, by a clockwise or opposite rotation of the delivery catheter, such that these parts of the docking device 1100 can be unsheathed or otherwise released while a position of the central region 1110 and the lower region 1120 of the docking device 1100 remains stationary or substantially in position relative to the surrounding anatomy.
  • FIG. 20 portions of device 1100 below the native valve are depicted with dotted lines.
  • a correct positioning of the docking device 1100 can be very important.
  • the docking device 1100 should be positioned relative to the native valve 1810 such that a desired part of the docking device 1100 extends through the native valve 1810 at or near commissure A3P3, and comes into contact with the atrial side of the native leaflets.
  • a proximal portion of the central region 1110 of the docking device 1100 extends between the proximal end of the covering or braid layer 1180 and the extension region 1140 , where the ePTFE or low friction layer 1170 remains exposed.
  • this ePTFE or low friction region is the part of the docking device 1100 that crosses the mitral plane and comes into contact with the atrial side of the native leaflets.
  • the portion of the docking device 1100 that passes through the mitral valve can be, for example, the part of the exposed central region 1110 just proximal to the end of the covering or braid layer 1180 , or can also include some of the proximal end of the covering or braid layer 1180 as well.
  • FIG. 21 shows a top view of a modified embodiment of the docking device 1100 , where two marker bands 1182 , 1184 have been added to the docking device 1100 .
  • the marker bands 1182 , 1184 are positioned next to one another. While the marker band(s) and/or visualization feature(s) can be placed at various locations, in FIG.
  • a first marker band 1182 is positioned at the proximal end of the high friction layer 1180 , while a second marker band 1184 is positioned a small distance away from the proximal end of the high friction layer 1180 .
  • One marker band 1182 can be made thicker than the other marker band 1184 , in order to easily tell them apart.
  • the marker bands 1182 , 1184 or other visualization feature(s) provide landmarks to easily identify the position of the proximal end of the high friction layer 1180 relative to both the delivery catheter and the native mitral anatomy.
  • a physician can use the marker bands 1182 , 1184 or other visualization feature(s) to determine when to stop advancing the docking device 1100 into the left ventricle (e.g., when the marker bands are at a desired orientation proximate commissure A3P3), and to start releasing or unsheathing the remaining proximal portion of the docking device 1100 into the left atrium.
  • the marker bands 1182 , 1184 are visualized under fluoroscopy or other 2D imaging modality, but the invention should not be limited thereto.
  • one or both marker bands are instead positioned on the low friction layer 1170 proximal to the end of the braid layer 1180 , or on other portions of the docking device 1100 , based on user preference. In other embodiments less or more marker bands can be used.
  • the braid layer 1180 can extend across the portion of the docking device coils that engages the replacement heart valve.
  • any of the docking devices herein can be further modified, for example, to ease or assist in advancement of the docking device to an appropriate position relative to the native valve. Modifications can also be made, for example, to help protect the native valve and other native heart tissue from being damaged by the docking device during implantation and positioning of the docking device.
  • the distal tip can be sized, shaped, and/or otherwise configured to more easily navigate around and encircle the chordae tendineae.
  • the distal tip should also be made in an atraumatic manner, such that advancement of the distal tip around and/or through the mitral or other valve anatomy will not damage the anatomy.
  • the proximal end of the docking device is attached to a pusher in the delivery catheter that pushes the docking device out of a distal opening of the catheter.
  • the terms pusher, pusher device, and push rod are used interchangeably herein and can be substituted for each other. While attached to the docking device, the pusher can assist in both pushing and pulling or retrieval of the docking device relative to the delivery catheter, in order to enable repositioning of the docking device at any stage throughout the delivery process.
  • Methods described herein can include various steps related to retrieval and repositioning of the docking device, e.g., retracting or pulling a push rod/suture/tether or other feature to pull/retract the docking device back into the delivery catheter, then repositioning and reimplanting the docking device in a different position/orientation or location.
  • a cover layer such as a fabric layer
  • adjustments of the docking device by the pusher can lead to friction forces applied against the cover layer, particularly at portions located at the proximal and distal ends of the docking device, for example, by the heart anatomy and/or by the pusher/push rod/pusher device itself.
  • the structure at the ends of the coil of the docking device and the connection techniques e.g., adhesion or suturing techniques
  • connection techniques e.g., adhesion or suturing techniques
  • the docking device 1100 can include atraumatic distal and proximal tips.
  • FIG. 22 shows a cross-section of the proximal tip of the docking device 1100 , showing the respective geometries of the wire core 1160 , for example, that can be made of NiTi, and a low friction cover layer 1170 , for example, that can be made of ePTFE or another polymer.
  • the low friction cover layer 1170 can extend slightly farther past the end of the wire core 1160 and taper down to a rounded tip.
  • the rounded extension region provides space for the low friction cover layer 1170 to anchor to and around the wire core 1160 , while also forming an atraumatic tip.
  • the distal tip of the docking device devices herein e.g., docking device 1100
  • the docking device 1100 can optionally further include securing holes 1164 near each of the proximal tip and distal tip.
  • the securing holes 1164 can be used to further secure the cover layer 1170 to the wire core 1160 , for example, via a suture or other tie-down.
  • This and/or similar securing measures can further prevent slipping or movement between the core 1160 and the cover layer 1170 during deployment and/or retrieval of the docking device 1100 .
  • the cover layer 1170 can be adhered, melted, molded, etc. around the core without suturing.
  • the distal tip of the docking device 1100 can be tapered slightly radially inwardly, for example, to be tangential to the circular shape formed by the coils of the central region 1110 .
  • the stabilization coil/turn or the upper region 1130 of the docking device 1100 can also taper slightly radially inwardly, for example, to be tangential (or have a portion that is tangential) to the circular shape formed by the coils of the central region 1110 , and can also be, for example, pointed slightly upwards towards the atrial ceiling and away from the other coils of the docking device 1100 .
  • the upper region 1130 of the docking device 1100 can be configured in this manner as a precautionary measure, for example, in case the docking device 1100 is not placed in the desired position discussed above and slides towards the left ventricle, where the upper region 1130 could potentially come into contact with the mitral plane, or if the docking device 1100 is being implanted into a heart with an abnormal anatomy.
  • the proximal end of the docking device 1100 can further include a second hole or bore 1162 .
  • the hole or bore 1162 can be sized such that a holding device, such as a long release/retrieval line or suture 1163 , can be looped therethrough for connecting or attaching the docking device 1100 to the distal end of the pusher or other feature of the delivery catheter.
  • the hole 1162 can be rounded and smooth to prevent unintended severing of the line/suture.
  • FIG. 22C illustrates a closer view of the release line/suture 163 looped through the bore 1162 of the docking device 1100 , where the exterior of the delivery catheter 1010 has been cut away.
  • a pusher device 1165 is configured as a pusher tube with a lumen extending therethrough, e.g., from end to end. The line/suture in this embodiment runs through a longitudinal bore through the pusher device/tube 1165 held within the delivery catheter 1010 .
  • the physician or other user can simply cut a proximal portion of the line/suture and pull the line/suture proximally to pass the cut end of the line/suture out through the hole 1162 , thereby releasing the docking device 1100 from the delivery catheter.
  • the line/suture can be looped and extended such that the line/suture extends from the bore 1162 through the pusher device/tube 1165 to a handle or hub external to the patient (the loop can be closed or open with two ends secured to the handle or hub).
  • FIG. 22B illustrates another embodiment of looping the line/suture 1163 to the proximal end of the coil, through bore 1162 .
  • FIG. 23 shows an exemplary end of a skeleton or coil skeleton or core of a docking device according to another embodiment of the invention that can be used at a distal end and/or a proximal end of the device.
  • the end of the coil/core 710 can be made of or include Nitinol, another shape memory metal or material, and/or non-shape memory materials.
  • the depicted end of the coil/core 710 has a substantially flat or rectangular cross-section, with a tip 712 (e.g., a ring-shaped tip, or other shape tip).
  • the rectangular cross-section shown can either be shaped in such manner only at an end of the coil 710 , or can extend for the length of the coil 710 , while in other embodiments, the entire coil 710 , including the distal end region and/or proximal end region, can have a more round cross-section or otherwise shaped cross-section.
  • the ring-shaped tip 712 has an enlarged or expanded width compared to other portions of the coil/core 710 , and defines a through hole 714 to facilitate passing through of one or more lines/sutures.
  • a free end 716 of the ring-shaped tip 712 can be arranged as a circular or otherwise curved arc, while an opposite end 718 of the tip 712 can be formed as a rounded or tapered transition portion between the tip 712 and an adjacent region of the coil 710 .
  • the coil 710 can further include one or more cover anchoring holes 720 to further assist in anchoring a cover layer that is placed over and attached to the coil 710 .
  • a cover layer that covers the skeleton/core 710 of the docking device can be, for example, one or more of the coverings or layers (e.g., low friction and/or high friction covering(s)) previously described.
  • the cover layer can be made of or include, for example, an ePTFE core tube that is wrapped with a woven PET cloth, or can be made of or include any other fabric or other biocompatible material.
  • Such a cover layer can be used to cover a majority of the docking device, for example, from a main body of the coil skeleton/core 710 up to or slightly over the end 718 of the tip 712 .
  • the cover layer can then be connected to the ring-shaped tip 712 , for example, via sutures that are passed through the through hole 714 and that go on top of and cover the arched free end region 716 .
  • the sutures serve to anchor the cover layer to the skeleton/core 710 , and also serve to soften the margins of the ring-shaped tip 712 .
  • Additional sutures can also be passed through the one or more cover anchoring holes 720 near the tip 712 , to provide additional anchoring of the cover layer to the skeleton/core 710 .
  • FIG. 24 shows an end of a skeleton or core of a docking device that can be used with any of the docking devices described herein at a proximal and/or distal end thereof.
  • the end of the coil/core 810 can also be made of or include Nitinol, another shape memory metal or material, and/or other non-shape memory materials.
  • the end of the coil/core 810 has a distal ball-shaped tip 812 .
  • the ball-shaped tip 812 can be preformed with the rest of the skeleton/core 810 , or can be a separate ball-shaped or a short cudgel-shaped addition with a rounded end that is welded to or otherwise attached to the end of the coil/core 810 .
  • the gap 814 is formed or left between the ball-shaped tip 812 and the rest of the coil/core 810 .
  • the gap 814 can be approximately 0.6 mm or any other size that is sufficient to facilitate passing through and/or crossing over of one or more sutures for anchoring or otherwise connecting a cover layer to the end of the coil/core 810 .
  • cover layer(s) or covering(s) that covers the coil skeleton/core 810 of the docking device can be similar to previously described cover layers or coverings.
  • the cover layer(s)/covering(s) can be made of or include, for example, an ePTFE core tube that is wrapped with a woven PET cloth, or can be made of or include any other fabric or other biocompatible material.
  • such a cover layer/covering covers a main body of the coil skeleton 810 , over the gap 814 , and up to or slightly over the ball-shaped tip 812 , while leaving a free end of the ball-shaped tip 812 exposed.
  • the cover layer/covering is then connected to the end of the coil 810 , for example, via sutures that are passed through the gap 814 .
  • the entire ball-shaped tip 812 is wrapped with and fully covered by the cover layer, and sutures are then passed through and/or crossed over the gap 814 to anchor the entire cover layer over the end of the ball-shaped tip 812 .
  • the tips 712 , 812 as shown and described with respect to FIGS. 23 and 24 provide their respective docking devices with ends that are rounded with compact noses that can help enable easier and more convenient navigation of their respective docking devices within the left ventricle.
  • the tips 712 , 812 since each of the tips 712 , 812 is curved or rounded, the tips 712 , 812 form ends with soft edges.
  • the shapes and structures at the ends of the respective coil skeletons 710 , 810 , the type, texture, and construction of the cover layer, and the suturing techniques for attaching the cover layer to the skeletons 710 , 810 also allow for tight connections between the tips 712 , 812 and the respective cover layers, without the use of glue or any other adhesives.
  • the tip construction and arrangements prevent exposure of any sharp edges, and also prevent surfaces of the skeletons 710 , 810 from cutting and/or protruding out of the cover layers, as a result of any friction forces that are applied to the cover layers of the docking devices during or after delivery.
  • the docking device can be attachable to a pusher that can more easily facilitate pushing and pulling of the docking device for delivery and readjusting purposes.
  • FIG. 25 shows an exemplary end of a coil skeleton/core 910 of a docking device 900 (which can be the same as or similar to other docking devices described herein) that can be used at a distal and/or proximal end
  • FIG. 26 shows the end of the docking device 900 , with a cover layer 920 over the coil skeleton/core 910 , and sutures 930 attaching the cover layer 920 to the coil skeleton/core 910 .
  • the coil skeleton/core 910 of the docking device 900 has an end region that has a substantially flat or rectangular cross-section, similar to the cross-section of the distal end of the coil/core 710 discussed above.
  • the rectangular cross-section shown can either be shaped in such manner only at the end region of the coil/core 910 , or can extend for the length of the coil/core 910 , while in other embodiments, the entire coil/core 910 , including the end region, can have a more round cross-section or otherwise shaped cross-section.
  • An oval or elongate slit hole 912 extends through the end region of the coil/core 910 , where two flanks 914 , 916 of the coil/core 910 extend along either side of the slit hole 912 to connect the proximal free end 918 of the coil/core 910 to the rest of the coil/core 910 .
  • the slit hole 912 has a width that is sufficient for passing through or crossing of a needle and/or one or more sutures 930 .
  • the covering/cover layer 920 can be, for example, a covering, fabric layer, or other layer the same as or similarly constructed as discussed above with respect to previous embodiments of the docking device.
  • the covering/cover layer 920 is wrapped around the coil skeleton/core 910 , and is anchored to or otherwise secured to the coil/core 910 by sutures 930 that run along and are passed through the slit hole 912 .
  • the sutures 930 can be crossed through the slit hole 912 in an “8” shape, as shown in FIG.
  • a suture 930 is passed through the slit hole 912 at least twice and is wrapped around the opposite flanks 914 , 916 of the coil/core 910 adjacent to the slit hole 912 at least one time each.
  • the suture 930 is passed through the slit hole 912 at least four times, and is wrapped around the flanks 914 , 916 at either side of the slit hole 912 at least two times each.
  • the sutures 930 are positioned at or moved towards a proximal portion of the slit hole 912 , near the free end 918 of the coil skeleton/core 910 , so that a distal end of the slit hole 912 remains exposed and accessible to a user, and stays open and large enough, for example, for a pull wire 940 (e.g., a release/retrieval suture) of a pusher of the delivery catheter to pass or cross through, thereby establishing a secure connection between the docking device 900 and the pusher.
  • the pull wire 940 can be a suture.
  • the pull wire 940 can be pulled proximally to retract the docking device 900 proximally as well. Similar steps can be used with other docking devices herein.
  • the sutures 930 serve to anchor and attach the cover layer 920 to the coil skeleton/core 910 , while also masking or covering the sharp edges of the slit hole 912 , to protect the pull wire 940 from being damaged or ruptured by the docking device 900 , and conversely to protect the docking device 900 from being damaged by the pull wire 940 , during retrieval or other pulling of the docking device 900 .
  • the shape and structure at the end of the coil skeleton/core 910 , the type, texture, and construction of the covering/cover layer 920 , and the connection technique (e.g., suturing technique) for attaching the covering/cover layer 920 to the coil skeleton/core 910 each contributes to a tight connection between the end of the coil 910 and the covering/cover layer 920 , and can be done with or without the use of glue or any other adhesives (e.g., the suturing technique does not require these).
  • the tip construction and arrangement prevents exposure of any sharp edges, and also prevents surfaces of the coil skeleton/core 910 from cutting and/or protruding out of the covering/cover layer 920 , as a result of any friction forces that are applied to the covering/cover layer 920 of the docking device 900 during or after delivery.
  • any or all of the different features from the different embodiments discussed above can be combined or modified, based on the needs of each individual patient.
  • the different features associated with the various different issues e.g., flexibility, increasing friction, protection
  • Embodiments of docking devices herein have generally been discussed above with respect to helping anchor replacement valves at the mitral position.
  • the docking devices as described or slightly modified versions thereof, can also be applied in similar manners to valve replacements at other valve sites as well, for example, at the tricuspid, pulmonary, or aortic positions.
  • Patients that are diagnosed with insufficiencies at either position can exhibit enlarged annuli that both prevent the native leaflets from properly coapting, and that also can cause the annuli to become too large, too soft, or too otherwise diseased to securely hold an expandable valve therein. Therefore, use of a rigid or semi-rigid docking device can also be beneficial for anchoring a replacement valve at those valve sites as well, for example, to prevent the replacement valves from dislodging during normal heart function.
  • the docking devices herein can further be covered with one or more coverings or cover layers, similarly as discussed above.
  • cover layer(s) for any of these applications can also be made of or include a material that promotes more rapid tissue ingrowth.
  • the cover layer can further be constructed to have a larger amount of surface area, for example, with a velour film, porous surface, braided surface, etc., to further bolster tissue ingrowth.
  • a possible access point for tricuspid replacement can be, for example, transseptal access
  • a possible access point for aortic replacement can be, for example, transfemoral access, although access to the respective valve sites is not limited thereto.
  • coil-shaped docking devices as previously described at the other valve sites can also serve to circumferentially cinch or clamp the native leaflets after deployment of the replacement valve at the native annulus, for example, by virtue of the leaflets and other tissue being sandwiched between coils of the docking device and being held in place by a spring force of the docking device, which further prevents slipping or other movement of the docking device and of the sandwiched tissue relative to the docking device, and prevents unwanted growth or expansion of the native annulus over time.
  • Some possible attachment configurations between the anchor/docking device and the release or retrieval line/suture and movement and/or sliding of the components might sometimes result in the anchor/docking device T-ing or “T-boning” with the pusher tube and/or delivery catheter, e.g., such that the axis of the pusher tube and/or delivery catheter is not aligned (and can be perpendicular) with the axis of a proximal end of the anchor/docking device.
  • pulling on the retrieval line/suture may result in the end portion 2700 of the docking device and the pusher device/tube 1165 and/or delivery catheter moving to an orthogonal or substantially orthogonal relative orientation, rather than an aligned orientation, e.g., they could become relatively oriented to form the shape of a “T”. If this happens, it can be difficult to retrieve or withdraw the anchor/docking device back into the delivery catheter.
  • any of the anchors/docking devices described herein can beneficially be configured and designed to inhibit, prevent, or resist this T-ing or “T-boning.”
  • any of the anchors/docking devices described herein can be configured with a curved proximal end that can more easily be pulled and guided into the delivery catheter without getting caught on the edges of the catheter and/or stuck out of alignment or perpendicular to the push tube and catheter.
  • any of the anchors/docking devices described herein can be configured such that a line of force F applied by a retrieval suture/line 1163 can be biased to be aligned with or substantially aligned (or biased toward alignment) with a central axis or area moment of inertia A of an end portion 2700 of the docking device (See FIG. 27C ).
  • This alignment can help inhibit and/or prevent the end portion 2700 of the docking device from relatively sliding or moving to one side of the pusher device or tube 1165 when the retrieval suture pulls the end portion 2700 of the docking device against the pusher device and/or when the docking device is pulled into the delivery catheter.
  • the docking device 1100 When tension is put on the release/retrieval suture 1163 , such as when attempting to retrieve the docking device 1100 , the docking device 1100 will generally follow the line of the tension as the docking device 1100 moves toward the pusher tube 1165 and/or delivery catheter. Some configurations may sometimes result in the end portion 2700 moving or sliding to the “T” orientation described above. For example, in some potential configurations, if the suture release holes 1162 are oriented radially outward on the docking device 1100 , the line tension force F from the release suture 1165 to the end portion 2700 may not be aligned with the axis or area moment of inertia A of the end portion 2700 of the anchor/docking device.
  • FIGS. 27A-30B exemplary embodiments of the docking devices 1100 that are provided with a proximal connection end or tip that maintains alignment or substantial alignment between the line of force F applied by a retrieval suture/line 1163 and the central axis or area moment of inertia A of an end portion 2700 of the docking device.
  • a proximal connection end or tip that maintains alignment or substantial alignment between the line of force F applied by a retrieval suture/line 1163 and the central axis or area moment of inertia A of an end portion 2700 of the docking device.
  • the docking device 1100 may be provided with a connection end/tip or spherical end/tip 1200 which can be integral with, molded, or machined on the end of the coil/core 1160 of the docking device 1100 or a cap that is attached to the proximal end of the coil/core 1160 by sutures, welding, adhesive, or other methods known in the art.
  • the spherical end or tip (e.g., a ball-shaped end or tip) can take a wide variety of different forms.
  • the spherical tip/end 1200 has a spherical portion 1202 , a transition portion 1204 , and a neck portion 1206 .
  • the spherical portion 1202 is at the proximal end of the spherical proximal tip/end 1200 .
  • the neck portion 1206 is distal to the spherical portion 1202 and connects to the coil/core 1110 of the docking device 900 .
  • the transition portion 1204 connects the spherical portion 1202 to the neck portion 1206 .
  • the spherical portion 1202 is substantially in the shape of a sphere or ball and the neck portion 1206 can be shaped and sized to either be a continuation of the coil/core 1160 of the docking device 1100 or to fit as a cap over the proximal end of the coil/core 1160 .
  • the transition portion 1204 provides a gradual and smooth transition between the larger diameter of the spherical portion 1202 and the smaller diameter of the neck portion 1204 .
  • the spherical proximal tip 1200 can have a wide variety of different shapes and sizes.
  • the spherical proximal tip/end 1200 includes a central passage 1210 which extends from the center/end of the spherical portion 1202 and along a tip axis AT that is aligned with the axis or area moment of inertia A ( FIG. 27A ).
  • the central passage extends through the spherical proximal tip 1200 into the center of the spherical portion 1202 .
  • two angled side passages 1212 extend to the central passage 1210 .
  • the illustrated passages 1212 start at locations on the outside surface of the spherical portion 1202 that are distal to the center of the spherical portion 1202 .
  • the side passages 1212 define a pair of openings in the exterior of the spherical proximal tip 1200 .
  • the side passage openings are positioned at a point substantially where the spherical portion 1202 and transition portion 1204 converge.
  • the side passage openings can be provided at a wide variety of different locations.
  • the side passages 1212 meet and open into the central passage 1210 at substantially the center of the spherical portion 1202 .
  • the central passage 1210 and side passages 1212 can define a smooth, forked passage.
  • the edges of the openings of the passages 1210 , 1212 and/or the intersections of the passages 1212 with the passage 1210 can be smoothed or rounded.
  • the central passage biases a suture passing therethrough to be aligned with (or toward alignment with) the central or longitudinal axis of the tip 1200 and end portion of the docking device.
  • the tip/end 1200 can include a covering(s) thereover.
  • the spherical tip 1200 has been described as having a central passage 1210 and two side passages 1212 , it will be appreciated that other designs are contemplated.
  • the tip 1200 can include a central opening at the proximal end of the tip 1200 and two angled passages can extend directly therefrom. The two angled passages can both open into the central opening and extend distally and radially outwardly therefrom.
  • one end of the retrieval or release suture/line 1163 is threaded through the central passage 1210 and one of the side passages 1210 , around an outer surface of the tip 1200 , into and through the other side passage 1210 , and out through the central passage 1210 . Threaded in such a manner, both ends of the suture/line 1163 extend from a proximal and central portion of the spherical connection tip 1200 such that the line of tension or force F applied by the suture/line 1163 on the tip 1200 is in-line with the longitudinal axis A of the end portion 2700 and the axis AT of the central passage of the tip 1200 .
  • the spherical shape of the spherical portion 1202 allows the distal end of the pusher tube 1165 and/or the delivery catheter 1010 to relatively rotate or pivot about the proximal portion of the docking device 1100 without the tip 1200 sliding off the end of the pusher tube and/or T-ing relative to the catheter 1010 .
  • the alignment of the line of tension F with the axes A,AT and/or the spherical proximal end of the tip 1200 prevent the docking device 1100 and pusher tube 1165 and/or delivery catheter 1010 from slipping past one another and T-boning.
  • the spherical proximal tip/end 1200 can optionally include a bore 1230 in the distal end of the tip 1200 to receive the proximal end of the coil/core 1160 of the docking device 1100 .
  • the bore 1230 terminates at a bore base 1232 .
  • the bore base 1232 can abut the proximal end of the inserted coil/core 1160 .
  • the bore base 1232 can be cylindrical, conical, or another shape.
  • the spherical proximal tip 1200 can optionally include an eyelet 1240 or slot in the neck portion 1206 which extends through the tip/end 1200 .
  • a suture can be passed through the eyelet 1240 and through a hole 1162 (See FIG.
  • An optional covering/cover layer can be provided over the coil/core and/or a portion, such as the neck portion 1206 , of the tip 1200 .
  • the eyelet or slot 1240 and hole 1206 can also be used to attach the optional covering layer.
  • the spherical connection tip/end 1200 can be integral with the docking device 1100 , can be machined onto the proximal end of the docking device 1100 , or can be a cap which is attached to the proximal end of the docking device by sutures, welding, or other attachment means.
  • the location of the central and side passages 1210 , 1212 allow for thicker walls which make the spherical tip/end 1200 more robust.
  • the spherical tip 1200 can be configured and designed such that the distal portion is larger in diameter than the end portion 2700 of the docking device 1100 ( FIG. 27A ) or such that the distal portion is flush with the end portion 2700 ( FIG. 27G ).
  • the tip/end 1200 can be integral with the docking device such that it does not require a bore 1230 or bore base 1232 , or the proximal end of the end portion 2700 can be reduced in diameter, such as by machining, to be receivable in the bore 1230 of the spherical proximal tip 1200 when the distal portion of the tip 1200 is to be flush with the end portion 2700 of the docking device.
  • Other methods of fitting the spherical proximal tip 1200 flush with the end portion 2700 of the docking device 1100 are also contemplated.
  • the spherical connection tip/end can be made in a wide variety of different ways.
  • the spherical tip/end 1200 can be made by zapping (e.g. electric discharge machining) the proximal end of the tip/end 1200 to create a sphere.
  • the central and side passages 1210 , 1212 can be formed by laser or micro-machining. Electropolishing can be used to create the radius on the edges.
  • the spherical tip/end 1200 can be made of Nitinol.
  • the tip/end 1200 can be made from other materials, such as PEEK (Polyether ether ketone), ultem or other polyetherimides, stainless steel, shape memory metal or material other than Nitinol, and/or other non-shape memory materials or any other material known in the art.
  • PEEK Polyether ether ketone
  • ultem or other polyetherimides stainless steel
  • shape memory metal or material other than Nitinol and/or other non-shape memory materials or any other material known in the art.
  • the spherical tip/end can be constructed to withstand 130 Newtons of force F applied by the suture without bending or breaking.
  • the spherical portion 1202 can have a small diameter, such as a diameter between 2.0 and 2.50 mm, such as between about 2.10 and 2.30 mm, such as 2.20 mm.
  • the neck portion 1206 can have a small outside diameter, such as an outside diameter between 1.10 and 1.50 mm, such as between about 1.20 and 1.40 mm, such as about 1.3 mm.
  • the transition portion 1204 can have a small radius, such as a radius between 0.8 and 1.20 mm, such as between about 0.90 and 1.10 mm, such as about 1.0 mm.
  • the central passage 1210 can have a wide variety of different shapes.
  • the central passage 1210 can have a circular opening, an oval opening, a conical opening, a square opening, etc.
  • the central passage 1210 has an oval opening to the proximal portion of the tip 1200 .
  • the oval opening can have a small size, such as an opening with a width between 0.95 and 1.30 mm, such as between about 1.03 and 1.23 mm, such as about 1.13 mm, and a height between 0.50 and 0.85 mm, such as between about 0.55 and 0.77 mm, such as about 0.65 mm.
  • the side passages can have a wide variety of different shapes.
  • the side passages 1212 have round openings with a diameter between 0.50 and 0.85 mm, such as between about 0.55 and 0.75 mm, such 0.65 mm.
  • the axis extending through each side passage 1212 can be at an angle between 115 and 135°, such as between about 120 and 130°, such as about 126°, from the longitudinal access extending through the central passage 1210 .
  • the edge between the bore 1230 and the bore base 1232 can be rounded.
  • the rounded edge can have a radius between about 0.1 and 0.4 mm, such as about 0.20 mm.
  • the bore 1230 can extend between 1.9 and 2.35 mm, such as between about 2.01 and 2.21 mm, such as about 2.11 mm, proximally into the tip 1200 from the distal end.
  • the eyelet 1240 is shaped with two semi-circles on either side of a rectangular portion.
  • the rectangular portion of the eyelet 1240 can be between 0.40 and 0.47 mm long, such as between about 0.46 and 0.66 mm, such as about 0.56 mm.
  • the semi-circular portions of the eyelet 1240 can have a radius between 0.125 and 0.25 mm, such as between about 0.15 and 0.20 mm, such as about 0.17 mm.
  • the distance from the distal end of the rectangular portion of the eyelet 1240 to the distal end of the spherical proximal tip 1200 can be between 0.7 and 1.1 mm, such as between about 0.8 mm and 1.0 mm, such as about 0.9 mm.
  • the spherical connection tip/end 1200 can be similar to the spherical tip/end of FIGS. 27A-27F (and include any of the features, dimensions, etc. described above), but have a recessed collar, annular recess, or channel 1220 , which can be configured to retain a portion of the release suture 1163 .
  • the spherical tip 1200 can have a spherical portion 1202 , a transition portion 1204 , a neck portion 1206 , a central passage 1210 , and two side passages 1212 . In the example illustrated by FIGS.
  • the transition portion 1204 can include the illustrated annular recess or channel 1220 having a smaller diameter than the spherical and neck portions 1202 , 1206 .
  • the annular recess 1220 can have the shape of a partial torroid and can extend around the circumference of the spherical tip 1200 .
  • the distal end of the side passages 1212 at least partially open into the annular recess 1220 and the surfaces of the annular recess 1220 and the edges where the side passages 1212 open into the annular recess may be smooth or otherwise rounded.
  • one end of the release suture 1163 is threaded through the central passage 1210 and one of the side passages 1210 , around a portion of the annular recess 1220 , into and through the other side passage 1210 , and out through the central passage 1210 . Threaded in such a manner, both ends of the release suture 1163 extend from a proximal and central portion of the tip 1200 such that the line of tension or force F applied by the release suture 1163 on the tip 1200 is in-line with the longitudinal axis A of the end portion 2700 and the axis AT of the central passage of the tip 1200 .
  • a portion of the release suture 1163 can remain in the annular recess 1220 . While the pusher tube 1165 and catheter 1010 are depicted as relatively short compared to the spherical proximal tip 1200 , the pusher tube 1165 and catheter 1010 can be extended to any length desirable.
  • the spherical shape of the spherical portion 1202 allows the distal end of the pusher tube 1165 to relatively rotate or pivot about the proximal portion of the docking device 1100 without the tip 1200 sliding off the end of the pusher tube.
  • the alignment of the line of tension F with the axes A,AT and/or the spherical proximal end of the tip 1200 prevent the docking device 1100 and pusher tube 1165 from slipping past one another and T-boning.
  • the spherical connection tip can be integral with the delivery device and/or its core or include a bore 1230 and bore base 1232 in the distal end of the tip 1200 to receive the proximal end of the coil/core 1160 of the docking device 1100 .
  • the bore base 1232 is conical, but it can also be cylindrical or another shape.
  • An optional covering/cover layer can be provided over the coil/core and/or a portion, such as the neck portion 1206 , of the tip 1200 .
  • the spherical proximal tip 1200 can be integral with the delivery device and/or core, can be machined onto the proximal end of the docking device 1100 , or can be a cap which is attached to the proximal end of the docking device by sutures, welding, adhesive, or other attachment means.
  • the spherical proximal tip 1200 can be designed such that the distal portion is larger in diameter than the end portion 2700 of the docking device 1100 ( FIG. 28A ) or such that the distal portion is flush with the end portion 2700 ( FIG. 28F ).
  • the spherical proximal tip 1200 can have a length between about 4.4 and 4.8 mm, such as about 4.6 mm.
  • the spherical portion 1202 can have a length between 0.9 and 1.3 mm, such as between about 1.0 and 1.2 mm, such as about 1.1 mm, and can have a diameter between 2.0 and 2.4 mm, such as between 2.10 and 2.30 mm, such as about 2.20 mm.
  • the neck portion 1206 can have a length between 1.8 and 2.2 mm, such as between about 1.9 and 2.1 mm, such as about 2.00 mm, and can have an outside diameter between 1.65 and 2.05 mm, such as between about 1.75 and 1.95 mm, such as about 1.85 mm.
  • the transition portion 1204 can have an overall length of about 1.5 mm. Where the transition portion 1204 meets the spherical and neck portions 1202 , 1206 , the transition portion 1204 can have a curved reduction in diameter reduction in diameter.
  • the annular recess 1220 can take a wide variety of different forms.
  • the annular recess 1220 can have a single diameter (when viewed in cross-section) or can have two or more different diameters.
  • the diameter or diameters of the annular recess is between 0.5 and 1.5 mm, such between as 0.6 and 1.2 mm, such between as 0.7 and 1.1 mm, such as between 0.8 and 1.0 mm.
  • the transition portion 1204 and the annular recess 1220 can be of any size and shape.
  • the opening of the central passage 1210 is stadium shaped, and can have a length between 0.95 and 1.30 mm, such as between about 1.03 and 1.23 mm, such as about 1.13 mm, and can have a height between 0.40 and 0.80 mm, such as between about 0.50 and 0.70 mm, such as about 0.60.
  • the angle formed between the longitudinal axis of the central passage 120 and the longitudinal axis of the side passages 1212 can be between 130 and 160°, such as between about 140 and 150°, such as 146°.
  • the side passages 1212 can have a diameter between 0.40 and 0.80 mm, such as between about 0.50 and 0.70 mm, such as about 0.60 mm.
  • the bore 1230 can be circular and can have a diameter between 0.7 and 1.05 mm, such as between 0.77 and 0.97 mm, such as about 0.87 mm, and extends between 1.9 and 2.35 mm, such as between about 2.01 and 2.21 mm, such as about 2.11 mm, proximally into the tip 1200 from the distal end.
  • the eyelet 1240 can be shaped with two semi-circles on either side of a rectangular portion.
  • the rectangular portion of the eyelet 1240 can be between 0.40 and 0.47 mm long, such as between about 0.46 and 0.66 mm, such as about 0.56 mm.
  • the semi-circular portions of the eyelet 1240 can have a radius between 0.125 and 0.25 mm, such as between about 0.15 and 0.20 mm, such as about 0.17 mm.
  • the distance from the distal end of the rectangular portion of the eyelet 1240 to the distal end of the spherical proximal tip 1200 is between 0.7 and 1.1 mm, such as between about 0.8 mm and 1.0 mm, such as about 0.9 mm.
  • FIGS. 29A-29E illustrate an exemplary embodiment of a docking device 1100 .
  • the docking device 1100 includes a looped proximal tip or end 1300 (e.g., includes a loop at the proximal tip/end).
  • the looped proximal tip 1300 can be created by machining or a similar process.
  • the looped proximal tip 1300 can be formed in a wide variety of different ways. Referring to FIG.
  • the proximal end of the coil/core 1160 is bent or folded to a distal point of the coil/core 1160 and attached to define an inner loop surface 1310 , an outer loop surface 1312 , and a suture receiving area H.
  • the release suture 1163 can then be looped through the suture receiving area H and used to retrieve the docking device 1100 as previously described.
  • the distal end of the pusher tube 1165 may abut the outer loop surface 1312 and may rotate or pivot along the outer loop surface 1312 .
  • the looped portion of the release suture 1163 can rotate along the inner loop surface 1310 such that the line of tension F applied by the release suture 1163 is or becomes substantially in-line with the axis or area moment of inertia A of the end portion of the docking device.
  • the alignment of the line of tension F and the axis A of the end portion 2700 and/or the ability of the outer loop surface 1312 to rotate relative to the pusher tube 1165 and/or delivery catheter 1010 prevent the docking device 1100 and pusher tube 1165 and/or catheter 1010 from slipping past one another. While the pusher tube 1165 and catheter 1010 are depicted in FIG. 29B as relatively short compared to the looped proximal tip 1300 , the pusher tube 1165 and catheter 1010 can be extended to any length desirable.
  • the looped proximal tip 1400 can be made by cutting or shaving a proximal portion of the coil/core 1160 , bending or folding the proximal tip of the docking device 1100 back onto itself, and connecting the proximal tip of the docking device 1100 to a distal point of the docking device.
  • a proximal portion of the tip 1400 is shaved to define a flat longitudinal surface 1302 along the length of the coil/core 1160 to a distal point 1304 .
  • the cut is made by wire grinding or laser cutting the coil/core 1160 .
  • the edges of the flat longitudinal surface 1302 can be rounded.
  • the flat longitudinal surface 1302 is rounded or tapered near the distal point 1304 .
  • the flat longitudinal surface 1302 is then folded back toward the distal point 1304 to define the inner loop surface 1310 and connected to the remainder of the coil/core 1160 at a connection point 1306 near the distal point 1304 .
  • the proximal end of the flat longitudinal surface 1302 is welded at the connection point 1306 .
  • other methods of connecting the flat longitudinal surface 1302 to the connection point 1306 are contemplated such as heat setting, using adhesives, etc., or the surface 1302 my abut the point 1306 without direct connection.
  • the looped proximal tip 1300 is designed and constructed to slide smoothly through the delivery catheter.
  • the lateral edges of the flat longitudinal surface 1302 can be rounded.
  • the outer loop surface 1312 can be rounded to provide a smooth transition to the remainder of the coil/core 1160 .
  • the looped proximal tip 1300 is made of Nitinol and can withstand 130 Newtons of force without bending or breaking, without breaking the weld, or without the loop collapsing.
  • the tip 1300 can be made from other materials, such as PEEK, ultem, stainless steel, shape memory metal or material other than Nitinol, and/or other non-shape memory materials.
  • the looped proximal tip 1300 can include a bore 1340 extending through the coil/core 1160 at a point distal to the connection point 1306 .
  • a suture or other attachment device can extend through the bore 1340 to connect the coil/core 1160 and a cover.
  • the bore 1340 can be sized such that the suture or other attachment device can be fit therethrough and the bore 1340 can be rounded and smooth.
  • the covering can extend, for example, to a point between the bore 1340 and connection point 1306 .
  • the coil/core 1160 can have a wide variety of different shapes and sizes.
  • the coil/core 1160 can have a thickness or diameter between 0.75 and 0.95 mm, such as about 0.85 mm.
  • the proximal portion of the core/coil 1160 at the flat longitudinal surface 1302 can be at least 0.4 mm thick, such as about 0.5 mm.
  • the height of the outer loop surface 1312 can be less than 2.0 mm, such as about 1.9 mm.
  • the height of the inner loop surface 1310 can be at least 0.4 mm, such as about 0.5 mm.
  • the length of the inner loop surface can be at least 1 mm, such as 1.20 mm.
  • the bore 1340 can be at most 3.0 mm from the proximal point of the outer loop surface, such as about 2.8 mm.
  • FIGS. 30A and 30B illustrate an exemplary embodiment of a docking device 900 or core of a docking device that is configured to align the line of force F applied by the retrieval suture 1163 with the central axis or area center of mass A of the end portion 2700 of the docking device.
  • the proximal end of the docking device 900 can include a recessed channel or groove 950 .
  • the depicted proximal end of the docking device 900 is similar to the proximal end depicted in FIGS. 25-26 and will be described as having similar features and reference numerals.
  • the groove 950 may be included at the proximal end of other designs having different shapes or configurations.
  • the groove 950 can be provided in the proximal free end of the coil/core 910 such that a central axis extending through the groove 950 is aligned with an axis extending through the hole 912 . That is, the center of the groove 950 is aligned with the center of the hole. In the illustrated example, both the groove 950 and the hole 912 are centered on the axis A of the end portion (See FIG. 30B ).
  • the groove 950 defines two proximal free ends, 918 a and 918 b , on either side of the groove 950 . A proximal recessed end 919 a is recessed from and parallel to the proximal free ends, 918 a and 918 b .
  • Groove walls 919 b extend perpendicularly and connect the proximal recessed end 919 a and the proximal free ends, 918 a and 918 b .
  • Proximal projections, 915 a and 915 b are between the groove 950 and the sides of the coil/core 910 .
  • the groove 950 and resulting proximal projections, 915 a and 915 b can be any size capable of maintaining a suture looped in place between the groove 950 and the hole 912 .
  • the protruding projections, 915 a and 915 b are configured to be short enough and close enough together to avoid catching on the catheter 1010 when pushing, retrieving, or positioning the docking device 1100 .
  • the proximal projections, 915 a and 915 b can be in line with and substantially the same thickness as the flanks, 914 , 916 , respectively.
  • the groove 950 is laser cut into the coil/core 910 .
  • the groove can be formed in a variety of different ways, for example, the groove can be machined.
  • the edges of the coil/core 910 can be rounded.
  • a suture 941 and/or retrieval suture/line 1163 can be inserted though the slit hole 912 , looped around the groove 950 , and tied or otherwise secured in a closed loop.
  • the suture 941 and/or retrieval suture/line 1163 is looped tightly enough in the groove 950 that it will stay in the groove 950 and not slip around or radially outside either proximal projection 915 a , 915 b .
  • the groove can be other shapes, for example, it can be cross shaped and the suture 941 and/or retrieval suture/line 1163 can be tied or otherwise secured through the cross shaped groove to further prevent slipping or movement of the suture 941 and/or retrieval suture/line 1163 .
  • the distal end of the retrieval suture/line 1163 can be attached to the suture 941 (or as discussed above, retrieval suture/line 1163 can be directly attached to the docking device in the groove 950 and not require or use a separate suture 941 ).
  • the suture/line 1163 can be looped around or tied to the suture 941 . As the release suture 1163 is pulled or otherwise retracted, tension is exerted on the suture 941 , which then pulls the docking device 900 toward the pusher tube 1165 .
  • the line of tension F exerted on the coil/core 910 by the release suture 1163 will extend through the proximal recessed end 919 a and be substantially aligned with or be biased to be aligned with (or biased toward alignment with) the central or longitudinal axis A of coil/core 910 or an end portion thereof.
  • This alignment will prevent the proximal end of the delivery device 900 from becoming dislodged from the pusher tube 1165 . While the pusher tube 1165 and catheter 1010 are depicted as relatively short compared to the proximal end of the docking device, the pusher tube 1165 and catheter 1010 can extend to any length.
  • the retrieval suture/line 1163 can be looped around or tied directly to the docking device. As the suture/line 1163 is pulled or otherwise retracted, tension is exerted on the docking device, which pulls the docking device 900 toward the pusher tube 1165 . As the retrieval suture/line 1164 remains tied around the slit hole 912 and groove 950 , the line of tension F exerted on the coil/core 910 by the release suture 1163 will extend through the proximal recessed end 919 a and be substantially aligned with the axis A coil/core 910 . This alignment will prevent the end of the delivery device 900 from becoming dislodged from the pusher tube 1165 .
  • the illustrated square edges and corners or the groove 950 and slit hole 912 can be rounded or otherwise. While the illustrated embodiment depicts the docking device 900 as being similar to that of FIG. 25 and having a substantially flat or rectangular cross-section, the proximal end can have any shape that will fit in the delivery catheter. For example, the proximal end can be circular or oval, and can have a U-shaped or otherwise rounded groove. Additionally, a groove or channel can be included in the looped proximal end 1300 of FIGS. 29A-29E .
  • any number of slits and groove can be included in the embodiment of FIGS. 30A and 30B .
  • the proximal end of the coil/core 910 can have two grooves (or any number) and two slit holes (or any number) which are perpendicular to each other.
  • a suture would be looped through each slit hole and groove and secured.
  • a release suture can then attach to the two sutures in the center of the two grooves and ensure that the applied tension force would remain aligned between the coil/core 910 and pusher tube 1165 .

Landscapes

  • Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Prostheses (AREA)
  • External Artificial Organs (AREA)
  • Materials For Medical Uses (AREA)
US15/902,956 2016-08-26 2018-02-22 Heart valve docking devices and systems Active 2038-03-27 US10722359B2 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
US15/902,956 US10722359B2 (en) 2016-08-26 2018-02-22 Heart valve docking devices and systems
BR122020025121-2A BR122020025121B1 (pt) 2018-02-22 2018-02-23 Dispositivo de encaixe para acoplar uma válvula protética e método de recuperação de um dispositivo de encaixe
EP18907294.5A EP3755269A4 (en) 2018-02-22 2018-02-23 HEART VALVE DRIVE DEVICES AND SYSTEMS
SG11202007778XA SG11202007778XA (en) 2018-02-22 2018-02-23 Heart valve docking devices and systems
JP2020544517A JP7177162B2 (ja) 2018-02-22 2018-02-23 心臓弁ドッキングデバイスおよびシステム
KR1020207026802A KR102581821B1 (ko) 2018-02-22 2018-02-23 심장 판막 도킹 디바이스 및 시스템
CA3090478A CA3090478A1 (en) 2018-02-22 2018-02-23 Heart valve docking devices and systems
EP24177295.3A EP4397279A3 (en) 2018-02-22 2018-02-23 Heart valve docking devices and systems
PCT/US2018/019545 WO2019164516A1 (en) 2018-02-22 2018-02-23 Heart valve docking devices and systems
BR112020016300-7A BR112020016300B1 (pt) 2018-02-22 2018-02-23 Sistema para implantar um dispositivo de encaixe
IL276763A IL276763B1 (en) 2018-02-22 2018-02-23 Heart valve anchoring devices and systems
CN201880091923.9A CN111970993B (zh) 2018-02-22 2018-02-23 心脏瓣膜对接装置和系统
AU2018409826A AU2018409826B2 (en) 2018-02-22 2018-02-23 Heart valve docking devices and systems
MX2020008522A MX2020008522A (es) 2018-02-22 2018-02-23 Dispositivos y sistemas de acoplamiento de valvulas cardiacas.
IL314204A IL314204A (en) 2018-02-22 2018-02-23 Heart valve anchoring devices and systems
NZ766755A NZ766755A (en) 2018-02-22 2018-02-23 Heart valve docking devices and systems
CN202410373028.3A CN118252670A (zh) 2018-02-22 2018-02-23 心脏瓣膜对接装置和系统
KR1020237032012A KR20230143617A (ko) 2018-02-22 2018-02-23 심장 판막 도킹 디바이스 및 시스템
US16/933,632 US11801133B2 (en) 2016-08-26 2020-07-20 Heart valve docking devices and systems
MX2024005354A MX2024005354A (es) 2018-02-22 2020-08-14 Dispositivos y sistemas de acoplamiento de valvulas cardiacas.
AU2022211922A AU2022211922B2 (en) 2018-02-22 2022-08-08 Heart valve docking devices and systems
JP2022179734A JP2023010781A (ja) 2018-02-22 2022-11-09 心臓弁ドッキングデバイスおよびシステム
US18/330,252 US20230310152A1 (en) 2016-08-26 2023-06-06 Heart valve docking devices and systems

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201662380117P 2016-08-26 2016-08-26
US201662395940P 2016-09-16 2016-09-16
US15/682,287 US10463479B2 (en) 2016-08-26 2017-08-21 Heart valve docking coils and systems
US15/902,956 US10722359B2 (en) 2016-08-26 2018-02-22 Heart valve docking devices and systems

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US15/682,287 Continuation-In-Part US10463479B2 (en) 2016-08-26 2017-08-21 Heart valve docking coils and systems

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US16/933,632 Continuation US11801133B2 (en) 2016-08-26 2020-07-20 Heart valve docking devices and systems

Publications (2)

Publication Number Publication Date
US20180177594A1 US20180177594A1 (en) 2018-06-28
US10722359B2 true US10722359B2 (en) 2020-07-28

Family

ID=67688534

Family Applications (2)

Application Number Title Priority Date Filing Date
US15/902,956 Active 2038-03-27 US10722359B2 (en) 2016-08-26 2018-02-22 Heart valve docking devices and systems
US16/933,632 Active 2038-01-17 US11801133B2 (en) 2016-08-26 2020-07-20 Heart valve docking devices and systems

Family Applications After (1)

Application Number Title Priority Date Filing Date
US16/933,632 Active 2038-01-17 US11801133B2 (en) 2016-08-26 2020-07-20 Heart valve docking devices and systems

Country Status (13)

Country Link
US (2) US10722359B2 (ja)
EP (2) EP3755269A4 (ja)
JP (2) JP7177162B2 (ja)
KR (2) KR102581821B1 (ja)
CN (2) CN118252670A (ja)
AU (2) AU2018409826B2 (ja)
BR (2) BR122020025121B1 (ja)
CA (1) CA3090478A1 (ja)
IL (2) IL314204A (ja)
MX (2) MX2020008522A (ja)
NZ (1) NZ766755A (ja)
SG (1) SG11202007778XA (ja)
WO (1) WO2019164516A1 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11234818B2 (en) * 2018-05-21 2022-02-01 Medtentia International Ltd Oy Annuloplasty device
US11833034B2 (en) * 2016-01-13 2023-12-05 Shifamed Holdings, Llc Prosthetic cardiac valve devices, systems, and methods

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8870950B2 (en) 2009-12-08 2014-10-28 Mitral Tech Ltd. Rotation-based anchoring of an implant
WO2011111047A2 (en) 2010-03-10 2011-09-15 Mitraltech Ltd. Prosthetic mitral valve with tissue anchors
US11653910B2 (en) 2010-07-21 2023-05-23 Cardiovalve Ltd. Helical anchor implantation
US9763657B2 (en) 2010-07-21 2017-09-19 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
WO2013021375A2 (en) 2011-08-05 2013-02-14 Mitraltech Ltd. Percutaneous mitral valve replacement and sealing
US8852272B2 (en) 2011-08-05 2014-10-07 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
WO2013021374A2 (en) 2011-08-05 2013-02-14 Mitraltech Ltd. Techniques for percutaneous mitral valve replacement and sealing
EP2741711B1 (en) 2011-08-11 2018-05-30 Tendyne Holdings, Inc. Improvements for prosthetic valves and related inventions
JP6219377B2 (ja) 2012-05-20 2017-10-25 テル ハショマー メディカル リサーチ インフラストラクチャー アンド サーヴィシーズ リミテッド 人工僧帽弁
EP4166111A1 (en) 2013-01-24 2023-04-19 Cardiovalve Ltd. Ventricularly-anchored prosthetic valves
EP4066786A1 (en) 2014-07-30 2022-10-05 Cardiovalve Ltd. Articulatable prosthetic valve
EP3253333B1 (en) 2015-02-05 2024-04-03 Cardiovalve Ltd Prosthetic valve with axially-sliding frames
US10531866B2 (en) 2016-02-16 2020-01-14 Cardiovalve Ltd. Techniques for providing a replacement valve and transseptal communication
US20190231525A1 (en) 2016-08-01 2019-08-01 Mitraltech Ltd. Minimally-invasive delivery systems
CA3031187A1 (en) 2016-08-10 2018-02-15 Cardiovalve Ltd. Prosthetic valve with concentric frames
US10888421B2 (en) 2017-09-19 2021-01-12 Cardiovalve Ltd. Prosthetic heart valve with pouch
US10537426B2 (en) 2017-08-03 2020-01-21 Cardiovalve Ltd. Prosthetic heart valve
US12064347B2 (en) 2017-08-03 2024-08-20 Cardiovalve Ltd. Prosthetic heart valve
US11793633B2 (en) 2017-08-03 2023-10-24 Cardiovalve Ltd. Prosthetic heart valve
US11246704B2 (en) 2017-08-03 2022-02-15 Cardiovalve Ltd. Prosthetic heart valve
US10575948B2 (en) 2017-08-03 2020-03-03 Cardiovalve Ltd. Prosthetic heart valve
GB201720803D0 (en) 2017-12-13 2018-01-24 Mitraltech Ltd Prosthetic Valve and delivery tool therefor
GB201800399D0 (en) 2018-01-10 2018-02-21 Mitraltech Ltd Temperature-control during crimping of an implant
WO2019195860A2 (en) 2018-04-04 2019-10-10 Vdyne, Llc Devices and methods for anchoring transcatheter heart valve
JP7421546B2 (ja) * 2018-08-21 2024-01-24 シファメド・ホールディングス・エルエルシー 人工心弁デバイス、システム、および方法
US11344413B2 (en) 2018-09-20 2022-05-31 Vdyne, Inc. Transcatheter deliverable prosthetic heart valves and methods of delivery
US11071627B2 (en) 2018-10-18 2021-07-27 Vdyne, Inc. Orthogonally delivered transcatheter heart valve frame for valve in valve prosthesis
US10595994B1 (en) 2018-09-20 2020-03-24 Vdyne, Llc Side-delivered transcatheter heart valve replacement
US10321995B1 (en) 2018-09-20 2019-06-18 Vdyne, Llc Orthogonally delivered transcatheter heart valve replacement
US11278437B2 (en) 2018-12-08 2022-03-22 Vdyne, Inc. Compression capable annular frames for side delivery of transcatheter heart valve replacement
EP3860519A4 (en) 2018-10-05 2022-07-06 Shifamed Holdings, LLC HEART VALVE PROSTHESIS, SYSTEMS AND PROCEDURES
EP3866900A4 (en) * 2018-10-19 2022-06-22 Shifamed Holdings, LLC ADJUSTABLE MEDICAL DEVICE
US11109969B2 (en) 2018-10-22 2021-09-07 Vdyne, Inc. Guidewire delivery of transcatheter heart valve
CN113226223A (zh) 2018-11-20 2021-08-06 爱德华兹生命科学公司 用于将装置递送至天然心脏瓣膜的部署工具和方法
US10653522B1 (en) 2018-12-20 2020-05-19 Vdyne, Inc. Proximal tab for side-delivered transcatheter heart valve prosthesis
US11253359B2 (en) 2018-12-20 2022-02-22 Vdyne, Inc. Proximal tab for side-delivered transcatheter heart valves and methods of delivery
US11273032B2 (en) 2019-01-26 2022-03-15 Vdyne, Inc. Collapsible inner flow control component for side-deliverable transcatheter heart valve prosthesis
US11185409B2 (en) 2019-01-26 2021-11-30 Vdyne, Inc. Collapsible inner flow control component for side-delivered transcatheter heart valve prosthesis
EP3934583B1 (en) 2019-03-05 2023-12-13 Vdyne, Inc. Tricuspid regurgitation control devices for orthogonal transcatheter heart valve prosthesis
US10631983B1 (en) 2019-03-14 2020-04-28 Vdyne, Inc. Distal subannular anchoring tab for side-delivered transcatheter valve prosthesis
US10758346B1 (en) 2019-03-14 2020-09-01 Vdyne, Inc. A2 clip for side-delivered transcatheter mitral valve prosthesis
US11076956B2 (en) 2019-03-14 2021-08-03 Vdyne, Inc. Proximal, distal, and anterior anchoring tabs for side-delivered transcatheter mitral valve prosthesis
US11173027B2 (en) 2019-03-14 2021-11-16 Vdyne, Inc. Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same
WO2020191216A1 (en) 2019-03-19 2020-09-24 Shifamed Holdings, Llc Prosthetic cardiac valve devices, systems, and methods
EP3965701A4 (en) 2019-05-04 2023-02-15 Vdyne, Inc. CINCH DEVICE AND METHOD FOR DEPLOYING A SIDE-PLACED PROSTHETIC HEART VALVE IN A NATIVE RING
MX2021014283A (es) 2019-06-07 2022-01-06 Edwards Lifesciences Corp Sistemas, dispositivos y metodos para tratar valvulas cardiacas.
JP2022544774A (ja) * 2019-08-14 2022-10-21 イノバルブ バイオ メディカル リミテッド 房室弁の交換
AU2020334080A1 (en) 2019-08-20 2022-03-24 Vdyne, Inc. Delivery and retrieval devices and methods for side-deliverable transcatheter prosthetic valves
CA3152632A1 (en) 2019-08-26 2021-03-04 Vdyne, Inc. Side-deliverable transcatheter prosthetic valves and methods for delivering and anchoring the same
EP3827785A1 (en) * 2019-11-29 2021-06-02 Medtentia International Ltd Oy Annuloplasty device
EP3827786B1 (en) * 2019-11-29 2023-11-15 HVR Cardio Oy Annuloplasty system
US11234813B2 (en) 2020-01-17 2022-02-01 Vdyne, Inc. Ventricular stability elements for side-deliverable prosthetic heart valves and methods of delivery
EP4114313A4 (en) * 2020-03-03 2024-03-20 Shifamed Holdings, LLC HEART VALVE PROSTHESIS DEVICES, SYSTEMS AND METHODS
CN116456937A (zh) 2020-08-31 2023-07-18 施菲姆德控股有限责任公司 假体瓣膜递送系统
EP4203857A4 (en) * 2020-08-31 2024-10-09 Shifamed Holdings Llc INTERFACE FOR PROSTHETIC HEART VALVE AND DELIVERY SYSTEMS
IL302466A (en) 2020-11-13 2023-06-01 Edwards Lifesciences Corp Devices and methods for flow control in a transport system
CN114099072B (zh) * 2021-02-22 2022-11-18 上海纽脉医疗科技有限公司 瓣叶捕捞装置、系统及装配方法
US20230044256A1 (en) * 2021-03-22 2023-02-09 Shifamed Holdings, Llc Anchor position verification for prosthetic cardiac valve devices
BR112023020993A2 (pt) 2021-04-14 2024-02-06 Edwards Lifesciences Corp Sistemas de distribuição para implantes
CN221600309U (zh) * 2021-10-08 2024-08-27 爱德华兹生命科学公司 一种递送设备
CN114869545A (zh) * 2022-03-31 2022-08-09 上海纽脉医疗科技股份有限公司 一种瓣叶捕获装置、系统及人工心脏瓣膜
CN220175318U (zh) 2022-04-14 2023-12-15 爱德华兹生命科学公司 一种用于构造成递送假体植入物的递送设备的柄部组件
WO2023244751A1 (en) 2022-06-16 2023-12-21 Edwards Lifesciences Corporation Fluid sealing mechanism for a catheter
TW202412718A (zh) 2022-06-20 2024-04-01 美商愛德華生命科學公司 用於植入物遞送設備之導管軸
WO2023249993A1 (en) 2022-06-23 2023-12-28 Edwards Lifesciences Corporation Implant delivery apparatus with a telescopic shaft
WO2024129448A1 (en) 2022-12-16 2024-06-20 Edwards Lifesciences Corporation Prosthetic valve docking device

Citations (124)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4035849A (en) 1975-11-17 1977-07-19 William W. Angell Heart valve stent and process for preparing a stented heart valve prosthesis
US4790843A (en) 1986-06-16 1988-12-13 Baxter Travenol Laboratories, Inc. Prosthetic heart valve assembly
US5059177A (en) 1990-04-19 1991-10-22 Cordis Corporation Triple lumen balloon catheter
WO1991017720A1 (en) 1990-05-18 1991-11-28 Henning Rud Andersen A valve prosthesis for implantation in the body and a catheter for implantating such valve prosthesis
US5411552A (en) 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5554185A (en) 1994-07-18 1996-09-10 Block; Peter C. Inflatable prosthetic cardiovascular valve for percutaneous transluminal implantation of same
DE19532846A1 (de) 1995-09-06 1997-03-13 Georg Dr Berg Ventileinrichtung
EP0850607A1 (en) 1996-12-31 1998-07-01 Cordis Corporation Valve prosthesis for implantation in body channels
DE19907646A1 (de) 1999-02-23 2000-08-24 Georg Berg Ventileinrichtung zum Einsetzen in ein Hohlorgan
WO2001049213A2 (en) 1999-12-31 2001-07-12 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
WO2001054625A1 (en) 2000-01-31 2001-08-02 Cook Biotech Incorporated Stent valves and uses of same
US20020032481A1 (en) 2000-09-12 2002-03-14 Shlomo Gabbay Heart valve prosthesis and sutureless implantation of a heart valve prosthesis
WO2002047575A2 (en) 2000-12-15 2002-06-20 Angiomed Gmbh & Co. Medizintechnik Kg Stent with valve
US6419696B1 (en) 2000-07-06 2002-07-16 Paul A. Spence Annuloplasty devices and related heart valve repair methods
US6425916B1 (en) 1999-02-10 2002-07-30 Michi E. Garrison Methods and devices for implanting cardiac valves
US20020107535A1 (en) 2001-02-08 2002-08-08 Jeng Wei Union for connection of artificial vessel to human vessel
US6432134B1 (en) 1996-07-16 2002-08-13 Anson Medical Limited Method of producing a surgical implant
US6527979B2 (en) 1999-08-27 2003-03-04 Corazon Technologies, Inc. Catheter systems and methods for their use in the treatment of calcified vascular occlusions
WO2003028558A2 (en) 2001-10-01 2003-04-10 Ample Medical Corporation Methods and devices for heart valve treatments
US20030225420A1 (en) 2002-03-11 2003-12-04 Wardle John L. Surgical coils and methods of deploying
US20040111006A1 (en) 2002-12-17 2004-06-10 Scout Medical Technologies, Llc System and method for regulating blood pressure
EP1432369A1 (en) 2001-08-31 2004-06-30 Mitral Interventions Apparatus for valve repair
US6797002B2 (en) 2000-02-02 2004-09-28 Paul A. Spence Heart valve repair apparatus and methods
US20040193260A1 (en) 2001-12-05 2004-09-30 Alferness Clifton A. Anchor and pull mitral valve device and method
US20040260389A1 (en) 2003-04-24 2004-12-23 Cook Incorporated Artificial valve prosthesis with improved flow dynamics
EP1521550A2 (en) 2002-06-12 2005-04-13 Mitral Interventions, Inc. Method and apparatus for tissue connection
US20050119682A1 (en) 2001-10-30 2005-06-02 Eric Nguyen Vascular exclusion catheter
US20050119735A1 (en) 2002-10-21 2005-06-02 Spence Paul A. Tissue fastening systems and methods utilizing magnetic guidance
US20050137691A1 (en) 2003-12-23 2005-06-23 Sadra Medical Two piece heart valve and anchor
US20050182486A1 (en) 2004-02-13 2005-08-18 Shlomo Gabbay Support apparatus and heart valve prosthesis for sutureless implantation
US20050203614A1 (en) 2004-02-27 2005-09-15 Cardiacmd, Inc. Prosthetic heart valves, scaffolding structures, and systems and methods for implantation of same
WO2005102015A2 (en) 2004-04-23 2005-11-03 3F Therapeutics, Inc. Implantable prosthetic valve
WO2006011127A2 (en) 2004-07-30 2006-02-02 Niti Medical Technologies Ltd. Medical devices formed from shape memory alloys displaying a stress-retained martensitic state and method for use thereof
US7037334B1 (en) 2001-04-24 2006-05-02 Mitralign, Inc. Method and apparatus for catheter-based annuloplasty using local plications
US7077861B2 (en) 2000-07-06 2006-07-18 Medtentia Ab Annuloplasty instrument
US20060195134A1 (en) 2005-02-28 2006-08-31 Medtronic Vascular, Inc. Device, system, and method for aiding valve annuloplasty
US20060229561A1 (en) 2005-04-08 2006-10-12 Medtronic Vascular, Inc. Integrated detachable introducer
US20070010877A1 (en) 2003-12-23 2007-01-11 Amr Salahieh Methods and Apparatus for Endovascularly Replacing a Heart Valve
US20070027533A1 (en) 2005-07-28 2007-02-01 Medtronic Vascular, Inc. Cardiac valve annulus restraining device
WO2007067942A1 (en) 2005-12-07 2007-06-14 Arbor Surgical Technologies, Inc. Connection systems for two piece prosthetic heart valve assemblies
US20070203575A1 (en) 2006-02-27 2007-08-30 Cardiacmd, Inc., A California Corporation Methods and devices for delivery of prosthetic heart valves and other prosthetics
US20070265700A1 (en) 2005-10-26 2007-11-15 Eliasen Kenneth A Safety for Mitral Valve Plug
US20070293608A1 (en) 2006-06-19 2007-12-20 General Electric Company Polycarbonate compositions and articles formed therefrom
US7314485B2 (en) 2003-02-03 2008-01-01 Cardiac Dimensions, Inc. Mitral valve device using conditioned shape memory alloy
US20080077235A1 (en) 2006-08-11 2008-03-27 Kirson E D Annuloplasty with enhanced anchoring to the annulus based on tissue healing
WO2008048626A2 (en) 2006-10-18 2008-04-24 Guided Delivery Systems, Inc. Methods and devices for catheter advancement and delivery of substances therethrough
US7377941B2 (en) 2004-06-29 2008-05-27 Micardia Corporation Adjustable cardiac valve implant with selective dimensional adjustment
US20080172034A1 (en) 2002-07-02 2008-07-17 Patton Catherine C Methods Relating To Infusion Device
US20080208330A1 (en) 2005-02-28 2008-08-28 Olli Keranen Devices and a Kit for Improving the Function of a Heart Valve
US7445632B2 (en) 2003-05-05 2008-11-04 Rex Medical, L.P Percutaneous aortic valve
US20090192601A1 (en) 2008-01-24 2009-07-30 Medtronic Vascular, Inc. Infundibular Reducer Device Delivery System and Related Methods
WO2009155561A2 (en) 2008-06-20 2009-12-23 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves
US7637946B2 (en) 2006-02-09 2009-12-29 Edwards Lifesciences Corporation Coiled implant for mitral valve repair
US20100036484A1 (en) 2008-06-06 2010-02-11 Edwards Lifesciences Corporation Low profile transcatheter heart valve
US7708775B2 (en) 2005-05-24 2010-05-04 Edwards Lifesciences Corporation Methods for rapid deployment of prosthetic heart valves
US20100145440A1 (en) 2006-11-13 2010-06-10 Keraenen Olli Device And Method For Improving Function Of Heart Valve
US7737060B2 (en) 2006-03-31 2010-06-15 Boston Scientific Scimed, Inc. Medical devices containing multi-component fibers
US7785366B2 (en) 2005-10-26 2010-08-31 Maurer Christopher W Mitral spacer
WO2010121076A2 (en) 2009-04-15 2010-10-21 Cardiaq Valve Technologies, Inc. Vascular implant and delivery system
US20100312333A1 (en) 2009-04-29 2010-12-09 The Cleveland Clinic Foundation Apparatus and method for replacing a diseased cardiac valve
US20100318184A1 (en) 2000-02-02 2010-12-16 Spence Paul A Heart valve repair apparatus and methods
US7942927B2 (en) 2004-03-15 2011-05-17 Baker Medical Research Institute Treating valve failure
US8128691B2 (en) 2005-09-07 2012-03-06 Medtentia International Ltd. Oy Device and method for improving the function of a heart valve
US20120059458A1 (en) 2010-09-01 2012-03-08 Maurice Buchbinder Cardiac Valve Support Structure
US8142492B2 (en) 2006-06-21 2012-03-27 Aortx, Inc. Prosthetic valve implantation systems
US20120123529A1 (en) 2010-10-05 2012-05-17 Edwards Lifesciences Corporation Prosthetic heart valve
WO2012063228A1 (en) 2010-11-12 2012-05-18 Ht Consultant Di Giovanni Righini Prosthesis for cardiovascular valve
US8182529B2 (en) 2002-12-05 2012-05-22 Cardiac Dimensions, Inc. Percutaneous mitral valve annuloplasty device delivery method
US20120197379A1 (en) 2008-01-24 2012-08-02 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US20120283820A1 (en) 2009-09-18 2012-11-08 The Regents Of The University Of California Endovascular prosthetic heart valve replacement
US20130006352A1 (en) 2011-06-29 2013-01-03 Mitralix Ltd. Heart valve repair devices and methods
US8377115B2 (en) 2009-11-16 2013-02-19 Medtronic Vascular, Inc. Implantable valve prosthesis for treating venous valve insufficiency
US8398708B2 (en) 2010-03-05 2013-03-19 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves
US8449605B2 (en) 2006-06-28 2013-05-28 Kardium Inc. Method for anchoring a mitral valve
US8449606B2 (en) 2005-10-26 2013-05-28 Cardiosolutions, Inc. Balloon mitral spacer
US8454683B2 (en) 2006-04-12 2013-06-04 Medtronic Vascular, Inc. Annuloplasty device having a helical anchor and methods for its use
US20130190865A1 (en) 2012-01-25 2013-07-25 Boston Scientific Scimed, Inc. Valve assembly with a bioabsorbable gasket and a replaceable valve implant
EP2620125A1 (en) 2012-01-24 2013-07-31 Medtentia International Ltd Oy An arrangement, a loop-shaped support, a prosthetic heart valve and a method of repairing or replacing a native heart valve
WO2013114214A2 (en) 2012-01-31 2013-08-08 Orford Holdings Sa Mitral valve docking devices, systems and methods
US20130304197A1 (en) 2012-02-28 2013-11-14 Mvalve Technologies Ltd. Cardiac valve modification device
US8657872B2 (en) 2010-07-19 2014-02-25 Jacques Seguin Cardiac valve repair system and methods of use
US20140074299A1 (en) 2012-09-13 2014-03-13 Fanuc Corporation Themal dispalcement compensating device of machine tool
US20140081394A1 (en) 2011-05-04 2014-03-20 Medtentia International Ltd. Oy Medical Device For A Cardiac Valve Implant
US8685086B2 (en) 2006-02-18 2014-04-01 The Cleveland Clinic Foundation Apparatus and method for replacing a diseased cardiac valve
US20140214159A1 (en) 2011-08-11 2014-07-31 Tendyne Holdings, Inc. Prosthetic valves and related inventions
US8801776B2 (en) 2008-02-25 2014-08-12 Medtronic Vascular, Inc. Infundibular reducer devices
US8864823B2 (en) 2005-03-25 2014-10-21 StJude Medical, Cardiology Division, Inc. Methods and apparatus for controlling the internal circumference of an anatomic orifice or lumen
US20140324163A1 (en) 2011-11-12 2014-10-30 Medtentia International Ltd. Oy Device And Method For Improving Fixation Of A Medical Device
US20140358222A1 (en) 2011-12-21 2014-12-04 The Trustees Of The University Of Pennsylania Platforms for mitral valve replacement
US20150025623A1 (en) 2013-07-17 2015-01-22 Juan F. Granada System and method for cardiac valve repair and replacement
WO2015023579A1 (en) 2013-08-12 2015-02-19 Mitral Valve Technologies Sa Apparatus and methods for implanting a replacement heart valve
WO2015023862A2 (en) 2013-08-14 2015-02-19 Mitral Valve Technologies Sa Replacement heart valve apparatus and methods
US9078747B2 (en) 2011-12-21 2015-07-14 Edwards Lifesciences Corporation Anchoring device for replacing or repairing a heart valve
US9095434B2 (en) 2007-02-27 2015-08-04 Edwards Lifesciences Corporation Method and apparatus for replacing a prosthetic valve
US20150230921A1 (en) 2013-08-14 2015-08-20 Mitral Valve Technologies, Sarl Coiled anchor for supporting prosthetic heart valve, prosthetic heart valve, and deployment device
US20150245910A1 (en) 2012-11-20 2015-09-03 Giovanni Righini Device for the Deployment of a System of Guide Wires Within a Cardiac Chamber for Implanting a Prosthetic Heart Valve
US20150282931A1 (en) 2012-11-21 2015-10-08 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic heart valves
US9192471B2 (en) 2007-01-08 2015-11-24 Millipede, Inc. Device for translumenal reshaping of a mitral valve annulus
US20150335430A1 (en) 2007-10-19 2015-11-26 Guided Delivery Systems Inc. Systems and methods for cardiac remodeling
WO2015198125A1 (en) 2014-06-26 2015-12-30 Mitralix Ltd. Heart valve repair devices for placement in ventricle and delivery systems for implanting heart valve repair devices
US9237886B2 (en) 2007-04-20 2016-01-19 Medtronic, Inc. Implant for treatment of a heart valve, in particular a mitral valve, material including such an implant, and material for insertion thereof
US20160015514A1 (en) 2014-07-17 2016-01-21 Millipede, Inc. Prosthetic mitral valve with adjustable support
WO2016040881A1 (en) 2014-09-12 2016-03-17 Mitral Valve Technologies Sarl Mitral repair and replacement devices and methods
WO2016038017A1 (en) 2014-09-08 2016-03-17 Medtentia International Ltd Oy Annuloplasty implant
US20160095705A1 (en) 2013-05-21 2016-04-07 Medtentia International Ltd Oy Medical System For Annuloplasty
US9314335B2 (en) 2008-09-19 2016-04-19 Edwards Lifesciences Corporation Prosthetic heart valve configured to receive a percutaneous prosthetic heart valve implantation
US20160143732A1 (en) 2013-06-19 2016-05-26 Aga Medical Corporation Collapsible valve having paravalvular leak protection
WO2016101529A1 (zh) 2014-12-24 2016-06-30 金仕生物科技（常熟）有限公司 人工二尖瓣瓣膜持瓣器
US20160228247A1 (en) 2015-02-11 2016-08-11 Edwards Lifesciences Corporation Heart valve docking devices and implanting methods
US9463268B2 (en) 2010-09-07 2016-10-11 Paul A. Spence Cannula systems and methods
US20160346080A1 (en) 2014-02-04 2016-12-01 INNOVHEART S.r.I. Prosthetic device for a heart valve
US20170007402A1 (en) 2014-02-18 2017-01-12 Medtentia International Ltd Oy Medical Device for a Cardiac Valve Implant
US9597205B2 (en) 2012-06-06 2017-03-21 Magenta Medical Ltd. Prosthetic renal valve
US9622863B2 (en) 2013-11-22 2017-04-18 Edwards Lifesciences Corporation Aortic insufficiency repair device and method
WO2017103833A1 (en) 2015-12-15 2017-06-22 Innovheart S.R.L. Cardiac valve prosthesis
US20170217385A1 (en) 2016-02-03 2017-08-03 Audi Ag Circuit arrangement
US20170266005A1 (en) 2014-03-15 2017-09-21 Rex Medical, L.P. Vascular device for treating venous valve insufficiency
US20170281337A1 (en) 2015-09-02 2017-10-05 Edwards Lifesciences Corporation Spacer for securing a transcatheter valve to a bioprosthetic cardiac structure
US20180000580A1 (en) 2015-05-14 2018-01-04 Dan Wallace Replacement mitral valves
US20180085217A1 (en) 2015-02-13 2018-03-29 Millipede, Inc. Valve replacement using rotational anchors
US20180206074A1 (en) 2015-05-14 2018-07-19 Verint Systems Ltd. System and method for accurate location of wireless terminals using mobile interrogation device
US20180289481A1 (en) 2006-04-25 2018-10-11 Medtronic Vascular, Inc. Method for stabilizing a cardiac valve annulus
US20180303606A1 (en) 2015-02-12 2018-10-25 Medtronic, Inc. Integrated valve assembly and method of delivering and deploying an integrated valve assembly
US20180318080A1 (en) 2013-07-10 2018-11-08 Medtronic, Inc. Helical coil mitral valve annuloplasty systems and methods

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4781704A (en) 1987-02-24 1988-11-01 Entech, Inc. Feeding tube assembly with collapsible outlet connector
US5275152A (en) 1992-07-27 1994-01-04 Welch Allyn, Inc. Insertion tube terminator
US5658253A (en) 1995-02-21 1997-08-19 Abbott Laboratories Stylet device for guiding an enteral feeding tube
WO1996028200A1 (en) 1995-03-16 1996-09-19 Medtronic Ps Medical Partially disposable surgical imaging assembly
US5762637A (en) 1996-08-27 1998-06-09 Scimed Life Systems, Inc. Insert molded catheter tip
US6835185B2 (en) * 1998-12-21 2004-12-28 Micrus Corporation Intravascular device deployment mechanism incorporating mechanical detachment
JP3524788B2 (ja) 1998-12-24 2004-05-10 株式会社パイオラックス 制癌剤投与用体内留置カテーテル
US6405414B1 (en) 1999-05-19 2002-06-18 Contech Packaging, Inc. Coiling clip and improved spiral wound dispenser
EP1790372B2 (en) 2004-09-03 2017-03-01 Terumo Kabushiki Kaisha Indwelling needle assembly
ATE485760T1 (de) 2005-02-02 2010-11-15 Medical Components Inc Führungsdraht-erweiterungsanordnung
WO2007127477A2 (en) 2006-04-27 2007-11-08 Synecor, Llc Renal blood flow augmentation for congestive heart failure treatment
US8052750B2 (en) 2006-09-19 2011-11-08 Medtronic Ventor Technologies Ltd Valve prosthesis fixation techniques using sandwiching
EP2072027B1 (en) 2007-12-21 2020-06-17 Medtentia International Ltd Oy pre-annuloplasty device and method
EP2349433A4 (en) 2008-10-24 2017-06-14 Innerspace, Inc. Catheter air management system
US20120053680A1 (en) 2010-08-24 2012-03-01 Bolling Steven F Reconfiguring Heart Features
US9370418B2 (en) 2010-09-10 2016-06-21 Edwards Lifesciences Corporation Rapidly deployable surgical heart valves
US9096368B2 (en) 2011-01-19 2015-08-04 Boston Scientific Scimed, Inc. Medical device packaging and methods for preparing and packaging medical devices
US8931637B2 (en) 2011-05-04 2015-01-13 Cook Medical Technologies Llc Medical lumen access device assembly including medical lumen access device holder and method of use
ES2965612T3 (es) 2013-01-25 2024-04-16 Hvr Cardio Oy Un sistema médico con un dispositivo para recoger cuerdas y/o valvas
USD809136S1 (en) 2014-09-17 2018-01-30 Kirwan Surgical Products Llc Electrical connector and irrigation connector for irrigation cord assembly
US10314707B2 (en) * 2015-06-09 2019-06-11 Edwards Lifesciences, Llc Asymmetric mitral annuloplasty band
WO2017125170A1 (en) 2016-01-22 2017-07-27 Medtentia International Ltd Oy Annuloplasty implant
EP3231541B1 (en) 2016-04-14 2021-08-04 Sandvik Intellectual Property AB A face grooving tool body for metal cutting
JP6033979B1 (ja) 2016-05-12 2016-11-30 新幹工業株式会社 組織体形成装置
CR20190069A (es) * 2016-08-26 2019-05-14 Edwards Lifesciences Corp Valvulas y sistemas de acoplamiento de valvulas corazon
EP3906893A1 (en) * 2016-12-20 2021-11-10 Edwards Lifesciences Corporation Systems and mechanisms for deploying a docking device for a replacement heart valve
EP3395296B1 (en) 2017-04-28 2019-12-18 Medtentia International Ltd Oy Annuloplasty implant
HRP20231444T1 (hr) 2017-05-31 2024-03-01 Edwards Lifesciences Corporation Brtveni element za protetski srčani zalistak
WO2020191216A1 (en) 2019-03-19 2020-09-24 Shifamed Holdings, Llc Prosthetic cardiac valve devices, systems, and methods

Patent Citations (176)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4035849A (en) 1975-11-17 1977-07-19 William W. Angell Heart valve stent and process for preparing a stented heart valve prosthesis
US4790843A (en) 1986-06-16 1988-12-13 Baxter Travenol Laboratories, Inc. Prosthetic heart valve assembly
US5059177A (en) 1990-04-19 1991-10-22 Cordis Corporation Triple lumen balloon catheter
US6582462B1 (en) 1990-05-18 2003-06-24 Heartport, Inc. Valve prosthesis for implantation in the body and a catheter for implanting such valve prosthesis
EP0592410A1 (en) 1990-05-18 1994-04-20 Henning Rud Andersen HEART VALVE PROSTHESIS IMPLANTABLE INTO THE BODY AND CATHETER FOR THE IMPLANTATION OF SUCH A HEART VALVE PROSTHESIS.
US5411552A (en) 1990-05-18 1995-05-02 Andersen; Henning R. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis
US5840081A (en) 1990-05-18 1998-11-24 Andersen; Henning Rud System and method for implanting cardiac valves
US6168614B1 (en) 1990-05-18 2001-01-02 Heartport, Inc. Valve prosthesis for implantation in the body
WO1991017720A1 (en) 1990-05-18 1991-11-28 Henning Rud Andersen A valve prosthesis for implantation in the body and a catheter for implantating such valve prosthesis
US7618446B2 (en) 1990-05-18 2009-11-17 Edwards Lifesciences Ag Valve prosthesis for implantation in the body and a catheter for implanting such valve prosthesis
US5554185A (en) 1994-07-18 1996-09-10 Block; Peter C. Inflatable prosthetic cardiovascular valve for percutaneous transluminal implantation of same
DE19532846A1 (de) 1995-09-06 1997-03-13 Georg Dr Berg Ventileinrichtung
US6432134B1 (en) 1996-07-16 2002-08-13 Anson Medical Limited Method of producing a surgical implant
EP0850607A1 (en) 1996-12-31 1998-07-01 Cordis Corporation Valve prosthesis for implantation in body channels
US6908481B2 (en) 1996-12-31 2005-06-21 Edwards Lifesciences Pvt, Inc. Value prosthesis for implantation in body channels
US7585321B2 (en) 1996-12-31 2009-09-08 Edwards Lifesciences Pvt, Inc. Methods of implanting a prosthetic heart valve within a native heart valve
US20020151970A1 (en) 1999-02-10 2002-10-17 Garrison Michi E. Methods and devices for implanting cardiac valves
US6425916B1 (en) 1999-02-10 2002-07-30 Michi E. Garrison Methods and devices for implanting cardiac valves
DE19907646A1 (de) 1999-02-23 2000-08-24 Georg Berg Ventileinrichtung zum Einsetzen in ein Hohlorgan
US6527979B2 (en) 1999-08-27 2003-03-04 Corazon Technologies, Inc. Catheter systems and methods for their use in the treatment of calcified vascular occlusions
US7018408B2 (en) 1999-12-31 2006-03-28 Abps Venture One, Ltd. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
US20080125853A1 (en) 1999-12-31 2008-05-29 Abps Venture One, Ltd. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
US6458153B1 (en) 1999-12-31 2002-10-01 Abps Venture One, Ltd. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
WO2001049213A2 (en) 1999-12-31 2001-07-12 Advanced Bio Prosthetic Surfaces, Ltd. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
US6652578B2 (en) 1999-12-31 2003-11-25 Abps Venture One, Ltd. Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof
WO2001054625A1 (en) 2000-01-31 2001-08-02 Cook Biotech Incorporated Stent valves and uses of same
US20050096736A1 (en) 2000-01-31 2005-05-05 Osse Francisco J. Percutaneous heart valve devices
US6797002B2 (en) 2000-02-02 2004-09-28 Paul A. Spence Heart valve repair apparatus and methods
US20100318184A1 (en) 2000-02-02 2010-12-16 Spence Paul A Heart valve repair apparatus and methods
US6730121B2 (en) 2000-07-06 2004-05-04 Medtentia Annuloplasty devices and related heart valve repair methods
EP1296618B1 (en) 2000-07-06 2008-01-23 Medtentia AB Annuloplasty devices
US6419696B1 (en) 2000-07-06 2002-07-16 Paul A. Spence Annuloplasty devices and related heart valve repair methods
US7077861B2 (en) 2000-07-06 2006-07-18 Medtentia Ab Annuloplasty instrument
US20020032481A1 (en) 2000-09-12 2002-03-14 Shlomo Gabbay Heart valve prosthesis and sutureless implantation of a heart valve prosthesis
WO2002047575A2 (en) 2000-12-15 2002-06-20 Angiomed Gmbh & Co. Medizintechnik Kg Stent with valve
US20020107535A1 (en) 2001-02-08 2002-08-08 Jeng Wei Union for connection of artificial vessel to human vessel
US7037334B1 (en) 2001-04-24 2006-05-02 Mitralign, Inc. Method and apparatus for catheter-based annuloplasty using local plications
US7125421B2 (en) 2001-08-31 2006-10-24 Mitral Interventions, Inc. Method and apparatus for valve repair
EP1432369A1 (en) 2001-08-31 2004-06-30 Mitral Interventions Apparatus for valve repair
WO2003028558A2 (en) 2001-10-01 2003-04-10 Ample Medical Corporation Methods and devices for heart valve treatments
US20050119682A1 (en) 2001-10-30 2005-06-02 Eric Nguyen Vascular exclusion catheter
US20040193260A1 (en) 2001-12-05 2004-09-30 Alferness Clifton A. Anchor and pull mitral valve device and method
US20030225420A1 (en) 2002-03-11 2003-12-04 Wardle John L. Surgical coils and methods of deploying
US7101395B2 (en) 2002-06-12 2006-09-05 Mitral Interventions, Inc. Method and apparatus for tissue connection
EP1521550A2 (en) 2002-06-12 2005-04-13 Mitral Interventions, Inc. Method and apparatus for tissue connection
US20080172034A1 (en) 2002-07-02 2008-07-17 Patton Catherine C Methods Relating To Infusion Device
US20050119735A1 (en) 2002-10-21 2005-06-02 Spence Paul A. Tissue fastening systems and methods utilizing magnetic guidance
US8182529B2 (en) 2002-12-05 2012-05-22 Cardiac Dimensions, Inc. Percutaneous mitral valve annuloplasty device delivery method
US20040111006A1 (en) 2002-12-17 2004-06-10 Scout Medical Technologies, Llc System and method for regulating blood pressure
US7314485B2 (en) 2003-02-03 2008-01-01 Cardiac Dimensions, Inc. Mitral valve device using conditioned shape memory alloy
US20040260389A1 (en) 2003-04-24 2004-12-23 Cook Incorporated Artificial valve prosthesis with improved flow dynamics
US7445632B2 (en) 2003-05-05 2008-11-04 Rex Medical, L.P Percutaneous aortic valve
US20050137691A1 (en) 2003-12-23 2005-06-23 Sadra Medical Two piece heart valve and anchor
US20070010877A1 (en) 2003-12-23 2007-01-11 Amr Salahieh Methods and Apparatus for Endovascularly Replacing a Heart Valve
US20050182486A1 (en) 2004-02-13 2005-08-18 Shlomo Gabbay Support apparatus and heart valve prosthesis for sutureless implantation
WO2005084595A1 (en) 2004-02-27 2005-09-15 Cardiacmd, Inc. Prosthetic heart valve delivery systems and methods
US20050203617A1 (en) 2004-02-27 2005-09-15 Cardiacmd, Inc. Prosthetic heart valves, scaffolding structures, and systems and methods for implantation of same
US20050203614A1 (en) 2004-02-27 2005-09-15 Cardiacmd, Inc. Prosthetic heart valves, scaffolding structures, and systems and methods for implantation of same
US7942927B2 (en) 2004-03-15 2011-05-17 Baker Medical Research Institute Treating valve failure
US20060025857A1 (en) 2004-04-23 2006-02-02 Bjarne Bergheim Implantable prosthetic valve
WO2005102015A2 (en) 2004-04-23 2005-11-03 3F Therapeutics, Inc. Implantable prosthetic valve
US7377941B2 (en) 2004-06-29 2008-05-27 Micardia Corporation Adjustable cardiac valve implant with selective dimensional adjustment
WO2006011127A2 (en) 2004-07-30 2006-02-02 Niti Medical Technologies Ltd. Medical devices formed from shape memory alloys displaying a stress-retained martensitic state and method for use thereof
US7951195B2 (en) 2004-11-19 2011-05-31 Medtentia International Ltd. Oy Annuloplasty instrument
US20080033542A1 (en) 2004-11-19 2008-02-07 Per Antonsson Annuloplasty Instrument
EP1827314A1 (en) 2004-11-19 2007-09-05 Medtentia AB Annuloplasty instrument
US20060195134A1 (en) 2005-02-28 2006-08-31 Medtronic Vascular, Inc. Device, system, and method for aiding valve annuloplasty
US20080208330A1 (en) 2005-02-28 2008-08-28 Olli Keranen Devices and a Kit for Improving the Function of a Heart Valve
US8864823B2 (en) 2005-03-25 2014-10-21 StJude Medical, Cardiology Division, Inc. Methods and apparatus for controlling the internal circumference of an anatomic orifice or lumen
US20060229561A1 (en) 2005-04-08 2006-10-12 Medtronic Vascular, Inc. Integrated detachable introducer
US7708775B2 (en) 2005-05-24 2010-05-04 Edwards Lifesciences Corporation Methods for rapid deployment of prosthetic heart valves
US20070027533A1 (en) 2005-07-28 2007-02-01 Medtronic Vascular, Inc. Cardiac valve annulus restraining device
US20150335428A1 (en) 2005-09-07 2015-11-26 Medtentia International Ltd Oy Device And Method For Improving The Function Of A Heart Valve
US9119718B2 (en) 2005-09-07 2015-09-01 Medtentia International Ltd Oy Device and method for improving the function of a heart valve
US8128691B2 (en) 2005-09-07 2012-03-06 Medtentia International Ltd. Oy Device and method for improving the function of a heart valve
US8449606B2 (en) 2005-10-26 2013-05-28 Cardiosolutions, Inc. Balloon mitral spacer
US7785366B2 (en) 2005-10-26 2010-08-31 Maurer Christopher W Mitral spacer
US20070265700A1 (en) 2005-10-26 2007-11-15 Eliasen Kenneth A Safety for Mitral Valve Plug
WO2007067942A1 (en) 2005-12-07 2007-06-14 Arbor Surgical Technologies, Inc. Connection systems for two piece prosthetic heart valve assemblies
US7637946B2 (en) 2006-02-09 2009-12-29 Edwards Lifesciences Corporation Coiled implant for mitral valve repair
US8685086B2 (en) 2006-02-18 2014-04-01 The Cleveland Clinic Foundation Apparatus and method for replacing a diseased cardiac valve
US20070203575A1 (en) 2006-02-27 2007-08-30 Cardiacmd, Inc., A California Corporation Methods and devices for delivery of prosthetic heart valves and other prosthetics
US7737060B2 (en) 2006-03-31 2010-06-15 Boston Scientific Scimed, Inc. Medical devices containing multi-component fibers
US8454683B2 (en) 2006-04-12 2013-06-04 Medtronic Vascular, Inc. Annuloplasty device having a helical anchor and methods for its use
US20180289481A1 (en) 2006-04-25 2018-10-11 Medtronic Vascular, Inc. Method for stabilizing a cardiac valve annulus
US20070293608A1 (en) 2006-06-19 2007-12-20 General Electric Company Polycarbonate compositions and articles formed therefrom
US8142492B2 (en) 2006-06-21 2012-03-27 Aortx, Inc. Prosthetic valve implantation systems
US8672998B2 (en) 2006-06-28 2014-03-18 Kardium Inc. Method for anchoring a mitral valve
US8449605B2 (en) 2006-06-28 2013-05-28 Kardium Inc. Method for anchoring a mitral valve
US20080077235A1 (en) 2006-08-11 2008-03-27 Kirson E D Annuloplasty with enhanced anchoring to the annulus based on tissue healing
US8388680B2 (en) 2006-10-18 2013-03-05 Guided Delivery Systems, Inc. Methods and devices for catheter advancement and delivery of substances therethrough
WO2008048626A2 (en) 2006-10-18 2008-04-24 Guided Delivery Systems, Inc. Methods and devices for catheter advancement and delivery of substances therethrough
US20080172035A1 (en) 2006-10-18 2008-07-17 Starksen Niel F Methods and devices for catheter advancement and delivery of substances therethrough
US8734507B2 (en) 2006-11-13 2014-05-27 Medtentia International Ltd. Oy Device and method for improving function of heart valve
US20100145440A1 (en) 2006-11-13 2010-06-10 Keraenen Olli Device And Method For Improving Function Of Heart Valve
US8663322B2 (en) 2006-11-13 2014-03-04 Medtentia International Ltd. Oy Device and method for improving function of heart valve
US9192471B2 (en) 2007-01-08 2015-11-24 Millipede, Inc. Device for translumenal reshaping of a mitral valve annulus
US9095434B2 (en) 2007-02-27 2015-08-04 Edwards Lifesciences Corporation Method and apparatus for replacing a prosthetic valve
US9237886B2 (en) 2007-04-20 2016-01-19 Medtronic, Inc. Implant for treatment of a heart valve, in particular a mitral valve, material including such an implant, and material for insertion thereof
US20150335430A1 (en) 2007-10-19 2015-11-26 Guided Delivery Systems Inc. Systems and methods for cardiac remodeling
US20120197379A1 (en) 2008-01-24 2012-08-02 Medtronic, Inc. Delivery systems and methods of implantation for prosthetic heart valves
US20090192601A1 (en) 2008-01-24 2009-07-30 Medtronic Vascular, Inc. Infundibular Reducer Device Delivery System and Related Methods
US8801776B2 (en) 2008-02-25 2014-08-12 Medtronic Vascular, Inc. Infundibular reducer devices
US20100036484A1 (en) 2008-06-06 2010-02-11 Edwards Lifesciences Corporation Low profile transcatheter heart valve
US8323335B2 (en) 2008-06-20 2012-12-04 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves and methods for using
US8236049B2 (en) 2008-06-20 2012-08-07 Edwards Lifesciences Corporation Multipiece prosthetic mitral valve and method
US20090319037A1 (en) 2008-06-20 2009-12-24 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves
WO2009155561A2 (en) 2008-06-20 2009-12-23 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves
US9314335B2 (en) 2008-09-19 2016-04-19 Edwards Lifesciences Corporation Prosthetic heart valve configured to receive a percutaneous prosthetic heart valve implantation
WO2010121076A2 (en) 2009-04-15 2010-10-21 Cardiaq Valve Technologies, Inc. Vascular implant and delivery system
US20100312333A1 (en) 2009-04-29 2010-12-09 The Cleveland Clinic Foundation Apparatus and method for replacing a diseased cardiac valve
US20180318073A1 (en) 2009-09-18 2018-11-08 The Regents Of The University Of California Endovascular prosthetic heart valve replacement
US20120283820A1 (en) 2009-09-18 2012-11-08 The Regents Of The University Of California Endovascular prosthetic heart valve replacement
US8377115B2 (en) 2009-11-16 2013-02-19 Medtronic Vascular, Inc. Implantable valve prosthesis for treating venous valve insufficiency
US8398708B2 (en) 2010-03-05 2013-03-19 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic valves
US8657872B2 (en) 2010-07-19 2014-02-25 Jacques Seguin Cardiac valve repair system and methods of use
US20140172070A1 (en) 2010-07-19 2014-06-19 Jacques Seguin Cardiac valve repair system and methods of use
US20120059458A1 (en) 2010-09-01 2012-03-08 Maurice Buchbinder Cardiac Valve Support Structure
US9463268B2 (en) 2010-09-07 2016-10-11 Paul A. Spence Cannula systems and methods
US20120123529A1 (en) 2010-10-05 2012-05-17 Edwards Lifesciences Corporation Prosthetic heart valve
WO2012063228A1 (en) 2010-11-12 2012-05-18 Ht Consultant Di Giovanni Righini Prosthesis for cardiovascular valve
US20140081394A1 (en) 2011-05-04 2014-03-20 Medtentia International Ltd. Oy Medical Device For A Cardiac Valve Implant
EP2726018A2 (en) 2011-06-29 2014-05-07 Mitralix Ltd Heart valve repair devices and methods
US20160256276A1 (en) 2011-06-29 2016-09-08 Mitralix Ltd. Heart valve repair devices and methods
US20130006352A1 (en) 2011-06-29 2013-01-03 Mitralix Ltd. Heart valve repair devices and methods
US9364326B2 (en) 2011-06-29 2016-06-14 Mitralix Ltd. Heart valve repair devices and methods
US20140214159A1 (en) 2011-08-11 2014-07-31 Tendyne Holdings, Inc. Prosthetic valves and related inventions
US20140324163A1 (en) 2011-11-12 2014-10-30 Medtentia International Ltd. Oy Device And Method For Improving Fixation Of A Medical Device
US9078747B2 (en) 2011-12-21 2015-07-14 Edwards Lifesciences Corporation Anchoring device for replacing or repairing a heart valve
US20140358222A1 (en) 2011-12-21 2014-12-04 The Trustees Of The University Of Pennsylania Platforms for mitral valve replacement
EP2620125A1 (en) 2012-01-24 2013-07-31 Medtentia International Ltd Oy An arrangement, a loop-shaped support, a prosthetic heart valve and a method of repairing or replacing a native heart valve
EP2806829A2 (en) 2012-01-24 2014-12-03 Medtentia International Ltd Oy An arrangement, a loop-shaped support, a prosthetic heart valve and a method of repairing or replacing a native heart valve
WO2013110722A2 (en) 2012-01-24 2013-08-01 Medtentia International Ltd Oy An arrangement, a loop-shaped support, a prosthetic heart valve and a method of repairing or replacing a native heart valve
US9474599B2 (en) 2012-01-24 2016-10-25 Medtentia International Ltd Oy Arrangement, a loop-shaped support, a prosthetic heart valve and a method of repairing or replacing a native heart valve
US20170007399A1 (en) 2012-01-24 2017-01-12 Medtentia International Ltd. Oy Arrangement, a loop-shaped support, a prosthetic heart valve and a method of repairing or replacing a native heart valve
US20150039082A1 (en) 2012-01-24 2015-02-05 Medtentia International Ltd. Oy Arrangement, A Loop-Shaped Support, A Prosthetic Heart Valve And A Method Of Repairing Or Replacing A Native Heart Valve
US20130190865A1 (en) 2012-01-25 2013-07-25 Boston Scientific Scimed, Inc. Valve assembly with a bioabsorbable gasket and a replaceable valve implant
WO2013114214A2 (en) 2012-01-31 2013-08-08 Orford Holdings Sa Mitral valve docking devices, systems and methods
US20140379074A1 (en) 2012-01-31 2014-12-25 Mitral Valve Technologies Sa Mitral valve docking devices, systems and methods
US20130304197A1 (en) 2012-02-28 2013-11-14 Mvalve Technologies Ltd. Cardiac valve modification device
US9597205B2 (en) 2012-06-06 2017-03-21 Magenta Medical Ltd. Prosthetic renal valve
US20140074299A1 (en) 2012-09-13 2014-03-13 Fanuc Corporation Themal dispalcement compensating device of machine tool
US20150245910A1 (en) 2012-11-20 2015-09-03 Giovanni Righini Device for the Deployment of a System of Guide Wires Within a Cardiac Chamber for Implanting a Prosthetic Heart Valve
US20150282931A1 (en) 2012-11-21 2015-10-08 Edwards Lifesciences Corporation Retaining mechanisms for prosthetic heart valves
US20160095705A1 (en) 2013-05-21 2016-04-07 Medtentia International Ltd Oy Medical System For Annuloplasty
US20160143732A1 (en) 2013-06-19 2016-05-26 Aga Medical Corporation Collapsible valve having paravalvular leak protection
US20180318080A1 (en) 2013-07-10 2018-11-08 Medtronic, Inc. Helical coil mitral valve annuloplasty systems and methods
US20150025623A1 (en) 2013-07-17 2015-01-22 Juan F. Granada System and method for cardiac valve repair and replacement
US20160199177A1 (en) 2013-08-12 2016-07-14 Landon H. Tompkins Apparatus and methods for implanting a replacement heart valve
WO2015023579A1 (en) 2013-08-12 2015-02-19 Mitral Valve Technologies Sa Apparatus and methods for implanting a replacement heart valve
US20150230921A1 (en) 2013-08-14 2015-08-20 Mitral Valve Technologies, Sarl Coiled anchor for supporting prosthetic heart valve, prosthetic heart valve, and deployment device
US20160184095A1 (en) 2013-08-14 2016-06-30 Mitral Valve Technologies Sarl Replacement heart valve apparatus and methods
WO2015023862A2 (en) 2013-08-14 2015-02-19 Mitral Valve Technologies Sa Replacement heart valve apparatus and methods
US9622863B2 (en) 2013-11-22 2017-04-18 Edwards Lifesciences Corporation Aortic insufficiency repair device and method
US20160346080A1 (en) 2014-02-04 2016-12-01 INNOVHEART S.r.I. Prosthetic device for a heart valve
US20170007402A1 (en) 2014-02-18 2017-01-12 Medtentia International Ltd Oy Medical Device for a Cardiac Valve Implant
WO2015127264A1 (en) 2014-02-20 2015-08-27 Mitral Valve Technologies Sarl Coiled anchor for supporting prosthetic heart valve, prosthetic heart valve, and deployment device
US20170266005A1 (en) 2014-03-15 2017-09-21 Rex Medical, L.P. Vascular device for treating venous valve insufficiency
US20170273789A1 (en) 2014-06-26 2017-09-28 Mitralix Ltd. Heart valve repair devices for placement in ventricle and delivery systems for implanting heart valve repair devices
US20150374493A1 (en) 2014-06-26 2015-12-31 Mitralix Ltd. Heart valve repair devices for placement in ventricle and delivery systems for implanting heart valve repair devices
WO2015198125A1 (en) 2014-06-26 2015-12-30 Mitralix Ltd. Heart valve repair devices for placement in ventricle and delivery systems for implanting heart valve repair devices
US20160015514A1 (en) 2014-07-17 2016-01-21 Millipede, Inc. Prosthetic mitral valve with adjustable support
WO2016038017A1 (en) 2014-09-08 2016-03-17 Medtentia International Ltd Oy Annuloplasty implant
US20170273788A1 (en) 2014-09-08 2017-09-28 Medtentia International Ltd Oy Annuloplasty Implant
WO2016040881A1 (en) 2014-09-12 2016-03-17 Mitral Valve Technologies Sarl Mitral repair and replacement devices and methods
US20160074165A1 (en) 2014-09-12 2016-03-17 Mitral Valve Technologies Sarl Mitral repair and replacement devices and methods
WO2016101529A1 (zh) 2014-12-24 2016-06-30 金仕生物科技（常熟）有限公司 人工二尖瓣瓣膜持瓣器
WO2016130820A1 (en) 2015-02-11 2016-08-18 Edwards Lifesciences Corporation Heart valve docking devices and implanting methods
US20160228247A1 (en) 2015-02-11 2016-08-11 Edwards Lifesciences Corporation Heart valve docking devices and implanting methods
US20180303606A1 (en) 2015-02-12 2018-10-25 Medtronic, Inc. Integrated valve assembly and method of delivering and deploying an integrated valve assembly
US20180085217A1 (en) 2015-02-13 2018-03-29 Millipede, Inc. Valve replacement using rotational anchors
US20180000580A1 (en) 2015-05-14 2018-01-04 Dan Wallace Replacement mitral valves
US20180206074A1 (en) 2015-05-14 2018-07-19 Verint Systems Ltd. System and method for accurate location of wireless terminals using mobile interrogation device
US20170281337A1 (en) 2015-09-02 2017-10-05 Edwards Lifesciences Corporation Spacer for securing a transcatheter valve to a bioprosthetic cardiac structure
WO2017103833A1 (en) 2015-12-15 2017-06-22 Innovheart S.R.L. Cardiac valve prosthesis
US20170217385A1 (en) 2016-02-03 2017-08-03 Audi Ag Circuit arrangement

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11833034B2 (en) * 2016-01-13 2023-12-05 Shifamed Holdings, Llc Prosthetic cardiac valve devices, systems, and methods
US11234818B2 (en) * 2018-05-21 2022-02-01 Medtentia International Ltd Oy Annuloplasty device

Also Published As

Publication number Publication date
US20200345492A1 (en) 2020-11-05
JP2023010781A (ja) 2023-01-20
CN111970993A (zh) 2020-11-20
IL276763B1 (en) 2024-08-01
EP3755269A1 (en) 2020-12-30
CN118252670A (zh) 2024-06-28
BR112020016300B1 (pt) 2021-10-05
SG11202007778XA (en) 2020-09-29
BR112020016300A2 (pt) 2020-12-15
EP4397279A2 (en) 2024-07-10
AU2018409826A1 (en) 2020-08-20
AU2022211922B2 (en) 2024-09-19
IL276763A (en) 2020-10-29
WO2019164516A1 (en) 2019-08-29
US11801133B2 (en) 2023-10-31
BR122020025121B1 (pt) 2021-11-30
MX2020008522A (es) 2020-09-18
IL314204A (en) 2024-09-01
JP7177162B2 (ja) 2022-11-22
AU2018409826B2 (en) 2022-05-19
KR20230143617A (ko) 2023-10-12
CA3090478A1 (en) 2019-08-29
NZ766755A (en) 2023-05-26
EP3755269A4 (en) 2021-03-17
KR102581821B1 (ko) 2023-09-25
US20180177594A1 (en) 2018-06-28
KR20200115650A (ko) 2020-10-07
BR122020025121A2 (pt) 2021-02-09
MX2024005354A (es) 2024-05-20
CN111970993B (zh) 2024-04-12
EP4397279A3 (en) 2024-08-14
JP2021518775A (ja) 2021-08-05
AU2022211922A1 (en) 2022-09-01

Similar Documents

Publication Publication Date Title
AU2022211922B2 (en) Heart valve docking devices and systems
AU2023200569B2 (en) Heart valve docking coils and systems
US20230310152A1 (en) Heart valve docking devices and systems

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

AS Assignment

Owner name: EDWARDS LIFESCIENCES CORPORATION, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PATEL, DARSHIN S.;MANASH, BOAZ;PERLMUTTER, KHEN;AND OTHERS;SIGNING DATES FROM 20180307 TO 20180430;REEL/FRAME:045715/0001

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

STPP Information on status: patent application and granting procedure in general

Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED

STCF Information on status: patent grant

Free format text: PATENTED CASE

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 4